þ
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
|
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Maryland
|
|
45-0907772
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
Large accelerated filer
|
þ
|
|
Accelerated filer
|
o
|
Non-accelerated filer
|
o
|
(Do not check if a smaller reporting company)
|
Smaller Reporting Company
|
o
|
Emerging growth company
|
o
|
|
|
|
PART I. FINANCIAL INFORMATION
|
|
|
|
|
|
Item 1.
|
Financial Statements
|
|
Item 2.
|
Management's Discussion and Analysis of Financial Condition and Results of Operations
|
|
Item 3.
|
Quantitative and Qualitative Disclosures about Market Risk
|
|
Item 4.
|
Controls and Procedures
|
|
|
|
|
PART II. OTHER INFORMATION
|
|
|
Item 1.
|
Legal Proceedings
|
|
Item 1A.
|
Risk Factors
|
|
Item 2
|
Unregistered Sales of Equity Securities and Use of Proceeds
|
|
Item 3.
|
Defaults upon Senior Securities
|
|
Item 4.
|
Mine Safety Disclosures
|
|
Item 5.
|
Other Information
|
|
Item 6.
|
Exhibits
|
|
|
|
|
Signatures
|
|
|
March 31, 2018
|
|
December 31, 2017
|
||||
|
(unaudited)
|
|
|
||||
Assets:
|
|
|
|
||||
Agency securities, at fair value (including pledged securities of $3,434,631 and $3,581,868, respectively)
|
$
|
3,660,403
|
|
|
$
|
3,758,181
|
|
Non-agency securities, at fair value (including pledged securities of $760,144 and $743,278, respectively)
|
833,681
|
|
|
872,084
|
|
||
U.S. Treasury securities, at fair value (including pledged securities of $24,903 and $0, respectively)
|
24,924
|
|
|
—
|
|
||
Land
|
17,201
|
|
|
16,641
|
|
||
Buildings, furniture, fixtures and equipment, net of accumulated depreciation
|
259,775
|
|
|
240,352
|
|
||
Cash and cash equivalents
|
123,396
|
|
|
123,762
|
|
||
Restricted cash and cash equivalents
|
40,857
|
|
|
46,324
|
|
||
Interest receivable
|
14,919
|
|
|
14,608
|
|
||
Derivative assets, at fair value
|
29,726
|
|
|
14,712
|
|
||
Receivable under reverse repurchase agreements
|
836,901
|
|
|
843,130
|
|
||
Other assets
|
16,025
|
|
|
23,242
|
|
||
Total assets
|
$
|
5,857,808
|
|
|
$
|
5,953,036
|
|
Liabilities:
|
|
|
|
||||
Repurchase agreements
|
$
|
3,743,436
|
|
|
$
|
3,863,719
|
|
Notes payable, net of deferred financing costs
|
201,986
|
|
|
186,500
|
|
||
Payable for securities purchased
|
58,182
|
|
|
4,357
|
|
||
Derivative liabilities, at fair value
|
—
|
|
|
4,454
|
|
||
Dividend payable
|
24,016
|
|
|
24,016
|
|
||
Obligation to return securities borrowed under reverse repurchase agreements, at fair value
|
824,688
|
|
|
830,776
|
|
||
Accounts payable and other accrued liabilities
|
44,904
|
|
|
33,592
|
|
||
Total liabilities
|
4,897,212
|
|
|
4,947,414
|
|
||
Equity:
|
|
|
|
||||
Preferred stock, $0.01 par value; 50,000 shares authorized:
|
|
|
|
||||
8.125% Series A Cumulative Redeemable Preferred Stock; 2,200 shares issued and outstanding (aggregate liquidation preference of $55,000)
|
53,039
|
|
|
53,039
|
|
||
Common stock, $0.01 par value; 300,000 shares authorized, 45,798 issued and outstanding
|
458
|
|
|
458
|
|
||
Additional paid-in capital
|
1,122,797
|
|
|
1,122,729
|
|
||
Retained deficit
|
(216,497
|
)
|
|
(171,119
|
)
|
||
Total stockholders’ equity
|
959,797
|
|
|
1,005,107
|
|
||
Noncontrolling interests
|
799
|
|
|
515
|
|
||
Total equity
|
960,596
|
|
|
1,005,622
|
|
||
Total liabilities and equity
|
$
|
5,857,808
|
|
|
$
|
5,953,036
|
|
|
|
For the Three Months Ended March 31,
|
||||||
|
|
2018
|
|
2017
|
||||
Interest income:
|
|
|
|
|
||||
Agency securities
|
|
$
|
27,511
|
|
|
$
|
17,901
|
|
Non-agency securities
|
|
11,994
|
|
|
15,696
|
|
||
Other
|
|
125
|
|
|
160
|
|
||
Interest expense
|
|
(17,053
|
)
|
|
(10,165
|
)
|
||
Net interest income
|
|
22,577
|
|
|
23,592
|
|
||
|
|
|
|
|
||||
Healthcare real estate:
|
|
|
|
|
||||
Healthcare real estate income
|
|
7,760
|
|
|
3,315
|
|
||
Healthcare real estate expense
|
|
(5,795
|
)
|
|
(2,653
|
)
|
||
Net healthcare investment income
|
|
1,965
|
|
|
662
|
|
||
|
|
|
|
|
||||
Other gains (losses):
|
|
|
|
|
||||
Realized loss on agency securities, net
|
|
(1,940
|
)
|
|
(212
|
)
|
||
Realized gain on non-agency securities, net
|
|
4,154
|
|
|
12,714
|
|
||
Realized gain (loss) on periodic settlements of interest rate swaps, net
|
|
358
|
|
|
(2,660
|
)
|
||
Realized gain on other derivatives and securities, net
|
|
2,736
|
|
|
2,167
|
|
||
Unrealized loss on agency securities, net
|
|
(76,170
|
)
|
|
(115
|
)
|
||
Unrealized gain (loss) on non-agency securities, net
|
|
(3,337
|
)
|
|
13,014
|
|
||
Unrealized gain (loss) on other derivatives and securities, net
|
|
33,457
|
|
|
(2,839
|
)
|
||
Servicing income
|
|
50
|
|
|
2,558
|
|
||
Servicing expense
|
|
(250
|
)
|
|
(4,985
|
)
|
||
Total other gains (losses), net
|
|
(40,942
|
)
|
|
19,642
|
|
||
Expenses:
|
|
|
|
|
||||
Management fees
|
|
3,389
|
|
|
3,376
|
|
||
General and administrative expenses
|
|
1,578
|
|
|
1,719
|
|
||
Total expenses
|
|
4,967
|
|
|
5,095
|
|
||
Net income (loss)
|
|
(21,367
|
)
|
|
38,801
|
|
||
Dividend on preferred stock
|
|
(1,117
|
)
|
|
(1,117
|
)
|
||
Noncontrolling interest in net loss (income)
|
|
5
|
|
|
(2
|
)
|
||
Net income (loss) available to common stockholders
|
|
$
|
(22,479
|
)
|
|
$
|
37,682
|
|
|
|
|
|
|
||||
Net income (loss) per common share — basic and diluted
|
|
$
|
(0.49
|
)
|
|
$
|
0.82
|
|
|
|
|
|
|
||||
Weighted average common shares — basic
|
|
45,810
|
|
|
45,798
|
|
||
Weighted average common shares — diluted
|
|
45,822
|
|
|
45,806
|
|
||
|
|
|
|
|
||||
Dividend declared per common share
|
|
$
|
0.50
|
|
|
$
|
0.45
|
|
|
Preferred Stock
|
|
Common Stock
|
|
Additional
Paid-in
Capital
|
|
Retained
Earnings (Deficit)
|
|
Noncontrolling Interests
|
|
Total Equity
|
||||||||||||||||||
|
Shares
|
|
Amount
|
|
Shares
|
|
Amount
|
|
|||||||||||||||||||||
Balance, December 31, 2016
|
2,200
|
|
|
$
|
53,039
|
|
|
45,798
|
|
|
$
|
458
|
|
|
$
|
1,122,493
|
|
|
$
|
(243,260
|
)
|
|
$
|
315
|
|
|
$
|
933,045
|
|
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
38,799
|
|
|
2
|
|
|
38,801
|
|
||||||
Distribution to noncontrolling interest
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(11
|
)
|
|
(11
|
)
|
||||||
Stock-based compensation
|
—
|
|
|
—
|
|
|
|
|
|
|
|
|
34
|
|
|
—
|
|
|
—
|
|
|
34
|
|
||||||
Preferred dividends declared
|
|
|
|
|
|
|
|
|
|
|
|
|
—
|
|
|
(1,117
|
)
|
|
—
|
|
|
(1,117
|
)
|
||||||
Common dividends declared
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(20,609
|
)
|
|
—
|
|
|
(20,609
|
)
|
||||||
Balance, March 31, 2017
|
2,200
|
|
|
$
|
53,039
|
|
|
45,798
|
|
|
$
|
458
|
|
|
$
|
1,122,527
|
|
|
$
|
(226,187
|
)
|
|
$
|
306
|
|
|
$
|
950,143
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Balance, December 31, 2017
|
2,200
|
|
|
$
|
53,039
|
|
|
45,798
|
|
|
$
|
458
|
|
|
$
|
1,122,729
|
|
|
$
|
(171,119
|
)
|
|
$
|
515
|
|
|
$
|
1,005,622
|
|
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(21,362
|
)
|
|
(5
|
)
|
|
(21,367
|
)
|
||||||
Issuance of noncontrolling interest
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
293
|
|
|
293
|
|
||||||
Distribution to noncontrolling interest
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(4
|
)
|
|
(4
|
)
|
||||||
Stock-based compensation
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
68
|
|
|
—
|
|
|
—
|
|
|
68
|
|
||||||
Preferred dividends declared
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,117
|
)
|
|
—
|
|
|
(1,117
|
)
|
||||||
Common dividends declared
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(22,899
|
)
|
|
—
|
|
|
(22,899
|
)
|
||||||
Balance, March 31, 2018
|
2,200
|
|
|
$
|
53,039
|
|
|
45,798
|
|
|
$
|
458
|
|
|
$
|
1,122,797
|
|
|
$
|
(216,497
|
)
|
|
$
|
799
|
|
|
$
|
960,596
|
|
|
For the Three Months Ended March 31,
|
||||||
|
2018
|
|
2017
|
||||
CASH FLOWS FROM OPERATING ACTIVITIES:
|
|
|
|
||||
Net income (loss)
|
$
|
(21,367
|
)
|
|
$
|
38,801
|
|
Adjustments to reconcile net income to net cash flows from operating activities:
|
|
|
|
||||
Amortization of net premium on agency securities
|
4,486
|
|
|
5,481
|
|
||
Accretion of net discount on non-agency securities
|
(3,768
|
)
|
|
(6,783
|
)
|
||
Depreciation and amortization on real estate investments
|
2,059
|
|
|
771
|
|
||
Realization of cash flows from MSR
|
—
|
|
|
1,089
|
|
||
Unrealized loss (gain) on securities, MSR and derivatives, net
|
46,050
|
|
|
(10,060
|
)
|
||
Realized loss (gain) on agency securities, net
|
1,940
|
|
|
212
|
|
||
Realized gain on non-agency securities, net
|
(4,154
|
)
|
|
(12,714
|
)
|
||
Realized loss (gain) on other derivatives and securities, net
|
(3,094
|
)
|
|
592
|
|
||
Stock-based compensation
|
68
|
|
|
34
|
|
||
Increase in interest receivable
|
(311
|
)
|
|
(826
|
)
|
||
Decrease in other assets
|
4,024
|
|
|
4,799
|
|
||
Increase (decrease) in operating accounts payable and other accrued liabilities
|
(38
|
)
|
|
5,511
|
|
||
Net cash flows from operating activities
|
25,895
|
|
|
26,907
|
|
||
CASH FLOWS FROM INVESTING ACTIVITIES:
|
|
|
|
||||
Purchases of agency securities
|
(284,077
|
)
|
|
(485,296
|
)
|
||
Purchases of non-agency securities
|
(65,690
|
)
|
|
(77,819
|
)
|
||
Purchases of healthcare real estate investments
|
(21,984
|
)
|
|
(26,634
|
)
|
||
Proceeds from sale of agency securities
|
220,435
|
|
|
208,457
|
|
||
Proceeds from sale of non-agency securities
|
89,902
|
|
|
260,473
|
|
||
Proceeds from sale of MSR
|
3,193
|
|
|
43,823
|
|
||
Principal collections on agency securities
|
107,745
|
|
|
85,136
|
|
||
Principal collections on non-agency securities
|
18,776
|
|
|
43,258
|
|
||
Net proceeds from (payments on) reverse repurchase agreements
|
6,229
|
|
|
(847,588
|
)
|
||
Purchases of U.S. Treasury securities
|
(141,912
|
)
|
|
(332,959
|
)
|
||
Proceeds from sale of U.S. Treasury securities
|
153,449
|
|
|
1,193,721
|
|
||
Payments for the termination of interest rate swaps
|
—
|
|
|
(3,841
|
)
|
||
Other investing cash flows, net
|
10,788
|
|
|
(12,098
|
)
|
||
Net cash flows from investing activities
|
96,854
|
|
|
48,633
|
|
||
CASH FLOWS USED IN FINANCING ACTIVITIES:
|
|
|
|
||||
Dividends paid
|
(24,016
|
)
|
|
(19,436
|
)
|
||
Issuance of noncontrolling interest
|
293
|
|
|
—
|
|
||
Distributions to noncontrolling interest
|
(4
|
)
|
|
(11
|
)
|
||
Proceeds from repurchase agreements and Federal Home Loan Bank advances
|
5,503,995
|
|
|
5,987,161
|
|
||
Repayments on repurchase agreements and Federal Home Loan Bank advances
|
(5,624,278
|
)
|
|
(6,035,054
|
)
|
||
Proceeds from notes payable, net of deferred financing costs
|
15,938
|
|
|
19,774
|
|
||
Repayments of notes payable
|
(510
|
)
|
|
(93
|
)
|
||
Net cash flows used in financing activities
|
(128,582
|
)
|
|
(47,659
|
)
|
||
Net increase (decrease) in cash and cash equivalents and restricted cash
|
(5,833
|
)
|
|
27,881
|
|
||
Cash and cash equivalents and restricted cash at beginning of the period
|
170,086
|
|
|
136,645
|
|
||
Cash and cash equivalents and restricted cash at end of period
|
$
|
164,253
|
|
|
$
|
164,526
|
|
|
March 31, 2018
|
||||||||||
|
Fannie Mae
|
|
Freddie Mac
|
|
Total
|
||||||
Agency RMBS:
|
|
|
|
|
|
||||||
Par value
|
$
|
2,393,236
|
|
|
$
|
1,196,372
|
|
|
$
|
3,589,608
|
|
Unamortized premium
|
118,223
|
|
|
63,641
|
|
|
181,864
|
|
|||
Amortized cost
|
2,511,459
|
|
|
1,260,013
|
|
|
3,771,472
|
|
|||
Gross unrealized gains
|
688
|
|
|
281
|
|
|
969
|
|
|||
Gross unrealized losses
|
(75,332
|
)
|
|
(36,706
|
)
|
|
(112,038
|
)
|
|||
Agency RMBS, at fair value
|
$
|
2,436,815
|
|
|
$
|
1,223,588
|
|
|
$
|
3,660,403
|
|
|
|
|
|
|
|
||||||
Weighted average coupon as of March 31, 2018
|
3.61
|
%
|
|
3.73
|
%
|
|
3.65
|
%
|
|||
Weighted average yield as of March 31, 2018
|
2.82
|
%
|
|
2.96
|
%
|
|
2.87
|
%
|
|||
Weighted average yield for the three months ended March 31, 2018
|
2.94
|
%
|
|
3.12
|
%
|
|
3.00
|
%
|
|
|
March 31, 2018
|
||||||||||||||
|
|
Amortized Cost
|
|
Gross Unrealized Gain
|
|
Gross Unrealized Loss
|
|
Fair Value
|
||||||||
Agency RMBS:
|
|
|
|
|
|
|
|
|
||||||||
Fixed rate
|
|
$
|
3,698,545
|
|
|
$
|
718
|
|
|
$
|
(111,935
|
)
|
|
$
|
3,587,328
|
|
Adjustable rate
|
|
72,927
|
|
|
251
|
|
|
(103
|
)
|
|
73,075
|
|
||||
Total Agency RMBS
|
|
$
|
3,771,472
|
|
|
$
|
969
|
|
|
$
|
(112,038
|
)
|
|
$
|
3,660,403
|
|
|
December 31, 2017
|
||||||||||
|
Fannie Mae
|
|
Freddie Mac
|
|
Total
|
||||||
Agency RMBS:
|
|
|
|
|
|
||||||
Par value
|
$
|
2,485,055
|
|
|
$
|
1,117,551
|
|
|
$
|
3,602,606
|
|
Unamortized premium
|
127,008
|
|
|
63,466
|
|
|
190,474
|
|
|||
Amortized cost
|
2,612,063
|
|
|
1,181,017
|
|
|
3,793,080
|
|
|||
Gross unrealized gains
|
3,876
|
|
|
1,149
|
|
|
5,025
|
|
|||
Gross unrealized losses
|
(28,364
|
)
|
|
(11,560
|
)
|
|
(39,924
|
)
|
|||
Agency RMBS, at fair value
|
$
|
2,587,575
|
|
|
$
|
1,170,606
|
|
|
$
|
3,758,181
|
|
|
|
|
|
|
|
|
|||||
Weighted average coupon as of December 31, 2017
|
3.63
|
%
|
|
3.75
|
%
|
|
3.67
|
%
|
|||
Weighted average yield as of December 31, 2017
|
2.78
|
%
|
|
2.89
|
%
|
|
2.82
|
%
|
|||
Weighted average yield for the year ended December 31, 2017
|
2.67
|
%
|
|
2.69
|
%
|
|
2.68
|
%
|
|
|
December 31, 2017
|
||||||||||||||
|
|
Amortized Cost
|
|
Gross Unrealized Gain
|
|
Gross Unrealized Loss
|
|
Fair Value
|
||||||||
Agency RMBS:
|
|
|
|
|
|
|
|
|
||||||||
Fixed rate
|
|
$
|
3,717,285
|
|
|
$
|
3,707
|
|
|
$
|
(39,924
|
)
|
|
$
|
3,681,068
|
|
Adjustable rate
|
|
75,795
|
|
|
1,318
|
|
|
—
|
|
|
77,113
|
|
||||
Total Agency RMBS
|
|
$
|
3,793,080
|
|
|
$
|
5,025
|
|
|
$
|
(39,924
|
)
|
|
$
|
3,758,181
|
|
|
|
March 31, 2018
|
|
December 31, 2017
|
||||||||||||||||||||||||
|
|
|
|
|
|
Weighted Average
|
|
|
|
|
|
Weighted Average
|
||||||||||||||||
Estimated Weighted
Average Life |
|
Fair
Value
|
|
Amortized
Cost
|
|
Yield
|
|
Coupon
|
|
Fair
Value
|
|
Amortized
Cost
|
|
Yield
|
|
Coupon
|
||||||||||||
Less than or equal to three years
|
|
$
|
42,371
|
|
|
$
|
43,132
|
|
|
2.10
|
%
|
|
3.93
|
%
|
|
$
|
40,404
|
|
|
$
|
40,815
|
|
|
2.06
|
%
|
|
3.92
|
%
|
Greater than three years and less than or equal to five years
|
|
489,624
|
|
|
498,048
|
|
|
2.39
|
%
|
|
3.15
|
%
|
|
534,299
|
|
|
535,608
|
|
|
2.38
|
%
|
|
3.19
|
%
|
||||
Greater than five years and less than or equal to 10 years
|
|
2,872,403
|
|
|
2,967,793
|
|
|
2.94
|
%
|
|
3.74
|
%
|
|
3,149,565
|
|
|
3,182,468
|
|
|
2.90
|
%
|
|
3.75
|
%
|
||||
Greater than 10 years
|
|
256,005
|
|
|
262,499
|
|
|
3.15
|
%
|
|
3.55
|
%
|
|
33,913
|
|
|
34,189
|
|
|
2.98
|
%
|
|
3.50
|
%
|
||||
Total
|
|
$
|
3,660,403
|
|
|
$
|
3,771,472
|
|
|
2.87
|
%
|
|
3.65
|
%
|
|
$
|
3,758,181
|
|
|
$
|
3,793,080
|
|
|
2.82
|
%
|
|
3.67
|
%
|
|
|
For the Three Months Ended March 31,
|
||||||
|
|
2018
|
|
2017
|
||||
Proceeds from agency securities sold
|
|
$
|
220,435
|
|
|
$
|
208,457
|
|
Less agency securities sold, at cost
|
|
(222,375
|
)
|
|
(208,669
|
)
|
||
Realized loss on agency securities, net
|
|
$
|
(1,940
|
)
|
|
$
|
(212
|
)
|
|
|
|
|
|
||||
Gross realized gains on sale of agency securities
|
|
$
|
14
|
|
|
$
|
1,270
|
|
Gross realized losses on sale of agency securities
|
|
(1,954
|
)
|
|
(1,482
|
)
|
||
Realized loss on agency securities, net
|
|
$
|
(1,940
|
)
|
|
$
|
(212
|
)
|
|
|
March 31, 2018
|
||||||||||
|
|
Fannie Mae
|
|
Freddie Mac
|
|
Total
|
||||||
Fair Value of Agency Securities Pledged Under:
|
|
|
|
|
|
|
||||||
Financing agreements
|
|
$
|
2,294,011
|
|
|
$
|
1,140,080
|
|
|
$
|
3,434,091
|
|
Derivative agreements
|
|
80
|
|
|
460
|
|
|
540
|
|
|||
Total fair value
|
|
2,294,091
|
|
|
1,140,540
|
|
|
3,434,631
|
|
|||
Accrued interest on pledged agency RMBS
|
|
6,800
|
|
|
3,476
|
|
|
10,276
|
|
|||
Total Fair Value of Agency RMBS Pledged and Accrued Interest
|
|
$
|
2,300,891
|
|
|
$
|
1,144,016
|
|
|
$
|
3,444,907
|
|
|
|
December 31, 2017
|
||||||||||
|
|
Fannie Mae
|
|
Freddie Mac
|
|
Total
|
||||||
Fair Value of Agency Securities Pledged Under:
|
|
|
|
|
|
|
||||||
Financing agreements
|
|
$
|
2,443,591
|
|
|
$
|
1,137,587
|
|
|
$
|
3,581,178
|
|
Derivative agreements
|
|
84
|
|
|
606
|
|
|
690
|
|
|||
Total fair value
|
|
2,443,675
|
|
|
1,138,193
|
|
|
3,581,868
|
|
|||
Accrued interest on pledged agency RMBS
|
|
7,132
|
|
|
3,399
|
|
|
10,531
|
|
|||
Total Fair Value of Agency RMBS Pledged and Accrued Interest
|
|
$
|
2,450,807
|
|
|
$
|
1,141,592
|
|
|
$
|
3,592,399
|
|
|
|
March 31, 2018
|
|
December 31, 2017
|
||||||||||||||||||||
Remaining Maturity
|
|
Fair Value
|
|
Amortized
Cost
|
|
Accrued Interest
|
|
Fair Value
|
|
Amortized
Cost
|
|
Accrued Interest
|
||||||||||||
30 days or less
|
|
$
|
1,102,225
|
|
|
$
|
1,136,865
|
|
|
$
|
3,262
|
|
|
$
|
940,788
|
|
|
$
|
949,282
|
|
|
$
|
2,765
|
|
31 - 59 days
|
|
985,955
|
|
|
1,015,732
|
|
|
2,974
|
|
|
1,298,331
|
|
|
1,311,882
|
|
|
3,818
|
|
||||||
60 - 90 days
|
|
359,108
|
|
|
370,094
|
|
|
1,096
|
|
|
261,823
|
|
|
262,908
|
|
|
785
|
|
||||||
Greater than 90 days
|
|
986,803
|
|
|
1,019,398
|
|
|
2,944
|
|
|
1,080,236
|
|
|
1,091,195
|
|
|
3,161
|
|
||||||
Total
|
|
$
|
3,434,091
|
|
|
$
|
3,542,089
|
|
|
$
|
10,276
|
|
|
$
|
3,581,178
|
|
|
$
|
3,615,267
|
|
|
$
|
10,529
|
|
March 31, 2018
|
||||||||||||||||||||||||||||||
|
|
Fair
Value
|
|
Gross Unrealized
|
|
Amortized Cost
|
|
Premium (Discount)
|
|
Par/ Current Face
|
|
Weighted Average
|
||||||||||||||||||
Category
|
|
|
Gains
|
|
Losses
|
|
|
|
|
Coupon
(1)
|
|
Yield
|
||||||||||||||||||
Prime
|
|
$
|
139,841
|
|
|
$
|
9,529
|
|
|
$
|
(77
|
)
|
|
$
|
130,389
|
|
|
$
|
(13,262
|
)
|
|
$
|
143,651
|
|
|
3.86
|
%
|
|
5.89
|
%
|
CRT
|
|
300,338
|
|
|
16,465
|
|
|
(81
|
)
|
|
283,954
|
|
|
13,258
|
|
|
270,696
|
|
|
5.50
|
%
|
|
5.68
|
%
|
||||||
Alt-A
|
|
277,083
|
|
|
50,162
|
|
|
(628
|
)
|
|
227,549
|
|
|
(109,122
|
)
|
|
336,671
|
|
|
2.94
|
%
|
|
9.21
|
%
|
||||||
Option-ARM
|
|
84,683
|
|
|
12,790
|
|
|
—
|
|
|
71,893
|
|
|
(20,305
|
)
|
|
92,198
|
|
|
2.11
|
%
|
|
6.79
|
%
|
||||||
Subprime
|
|
13,337
|
|
|
873
|
|
|
—
|
|
|
12,464
|
|
|
(664
|
)
|
|
13,128
|
|
|
5.20
|
%
|
|
5.92
|
%
|
||||||
CMBS
|
|
18,399
|
|
|
171
|
|
|
(85
|
)
|
|
18,313
|
|
|
(187
|
)
|
|
18,500
|
|
|
5.68
|
%
|
|
6.04
|
%
|
||||||
Total
|
|
$
|
833,681
|
|
|
$
|
89,990
|
|
|
$
|
(871
|
)
|
|
$
|
744,562
|
|
|
$
|
(130,282
|
)
|
|
$
|
874,844
|
|
|
3.91
|
%
|
|
6.92
|
%
|
(1)
|
Coupon rates are floating, except for
$11.4 million
,
$5.6 million
,
$12.0 million
,
$13.3 million
and
$18.4 million
fair value of fixed-rate prime, CRT, Alt-A, subprime and CMBS non-agency securities, respectively, as of
March 31, 2018
.
|
December 31, 2017
|
||||||||||||||||||||||||||||||
|
|
Fair
Value
|
|
Gross Unrealized
|
|
Amortized Cost
|
|
Premium (Discount)
|
|
Par/ Current Face
|
|
Weighted Average
|
||||||||||||||||||
Category
|
|
|
Gains
|
|
Losses
|
|
|
|
|
Coupon
(1)
|
|
Yield
|
||||||||||||||||||
Prime
|
|
$
|
143,329
|
|
|
$
|
9,342
|
|
|
$
|
(12
|
)
|
|
$
|
133,999
|
|
|
$
|
(13,893
|
)
|
|
$
|
147,892
|
|
|
3.77
|
%
|
|
5.66
|
%
|
CRT
|
|
322,819
|
|
|
18,346
|
|
|
—
|
|
|
304,473
|
|
|
16,011
|
|
|
288,462
|
|
|
5.34
|
%
|
|
5.23
|
%
|
||||||
Alt-A
|
|
286,953
|
|
|
51,123
|
|
|
(774
|
)
|
|
236,604
|
|
|
(112,305
|
)
|
|
348,909
|
|
|
2.69
|
%
|
|
8.93
|
%
|
||||||
Option-ARM
|
|
86,886
|
|
|
13,114
|
|
|
—
|
|
|
73,772
|
|
|
(21,044
|
)
|
|
94,816
|
|
|
1.79
|
%
|
|
6.58
|
%
|
||||||
Subprime
|
|
13,374
|
|
|
929
|
|
|
—
|
|
|
12,445
|
|
|
(683
|
)
|
|
13,128
|
|
|
5.20
|
%
|
|
5.97
|
%
|
||||||
CMBS
|
|
18,723
|
|
|
387
|
|
|
—
|
|
|
18,336
|
|
|
(164
|
)
|
|
18,500
|
|
|
5.68
|
%
|
|
6.03
|
%
|
||||||
Total
|
|
$
|
872,084
|
|
|
$
|
93,241
|
|
|
$
|
(786
|
)
|
|
$
|
779,629
|
|
|
$
|
(132,078
|
)
|
|
$
|
911,707
|
|
|
3.73
|
%
|
|
6.59
|
%
|
(1)
|
Coupon rates are floating, except for
$11.8 million
,
$0.9 million
,
$12.2 million
,
$13.4 million
and
$18.7 million
fair value of fixed-rate prime, CRT, Alt-A, subprime and CMBS non-agency securities, respectively, as of
December 31, 2017
.
|
|
|
March 31, 2018
|
|
December 31, 2017
|
||||||||||||||||||||||||
|
|
|
|
|
|
Weighted Average
|
|
|
|
|
|
Weighted Average
|
||||||||||||||||
Estimated Weighted
Average Life
|
|
Fair Value
|
|
Amortized
Cost
|
|
Coupon
|
|
Yield
|
|
Fair
Value
|
|
Amortized
Cost
|
|
Coupon
|
|
Yield
|
||||||||||||
≤ 5 years
|
|
$
|
285,566
|
|
|
$
|
244,884
|
|
|
3.33
|
%
|
|
8.44
|
%
|
|
$
|
302,797
|
|
|
$
|
258,501
|
|
|
3.11
|
%
|
|
8.31
|
%
|
> 5 to ≤ 7 years
|
|
258,753
|
|
|
226,721
|
|
|
4.17
|
%
|
|
7.05
|
%
|
|
398,712
|
|
|
361,649
|
|
|
4.33
|
%
|
|
5.97
|
%
|
||||
> 7 years
|
|
289,362
|
|
|
272,957
|
|
|
4.35
|
%
|
|
5.43
|
%
|
|
170,575
|
|
|
159,479
|
|
|
3.61
|
%
|
|
5.18
|
%
|
||||
Total
|
|
$
|
833,681
|
|
|
$
|
744,562
|
|
|
3.91
|
%
|
|
6.92
|
%
|
|
$
|
872,084
|
|
|
$
|
779,629
|
|
|
3.73
|
%
|
|
6.59
|
%
|
|
|
For the Three Months Ended March 31,
|
||||||
|
|
2018
|
|
2017
|
||||
Proceeds from non-agency securities sold
|
|
$
|
89,901
|
|
|
$
|
260,473
|
|
Increase in receivable for securities sold
|
|
—
|
|
|
5,748
|
|
||
Less: non-agency securities sold, at cost
|
|
(85,747
|
)
|
|
(253,507
|
)
|
||
Realized gain on non-agency securities, net
|
|
$
|
4,154
|
|
|
$
|
12,714
|
|
|
|
|
|
|
||||
Gross realized gain on sale of non-agency securities
|
|
$
|
4,155
|
|
|
$
|
12,864
|
|
Gross realized loss on sale of non-agency securities
|
|
(1
|
)
|
|
(150
|
)
|
||
Realized gain on non-agency securities, net
|
|
$
|
4,154
|
|
|
$
|
12,714
|
|
|
|
March 31, 2018
|
|
December 31, 2017
|
||||||||||||||||||||
Remaining Maturity
|
|
Fair Value
|
|
Amortized
Cost |
|
Accrued Interest
|
|
Fair Value
|
|
Amortized
Cost |
|
Accrued Interest
|
||||||||||||
30 days or less
|
|
$
|
686,521
|
|
|
$
|
614,635
|
|
|
$
|
1,052
|
|
|
$
|
585,943
|
|
|
$
|
517,750
|
|
|
$
|
815
|
|
31 - 59 days
|
|
60,500
|
|
|
50,754
|
|
|
75
|
|
|
97,537
|
|
|
82,105
|
|
|
145
|
|
||||||
60 - 90 days
|
|
13,123
|
|
|
10,311
|
|
|
17
|
|
|
59,798
|
|
|
58,651
|
|
|
135
|
|
||||||
Total
|
|
$
|
760,144
|
|
|
$
|
675,700
|
|
|
$
|
1,144
|
|
|
$
|
743,278
|
|
|
$
|
658,506
|
|
|
$
|
1,095
|
|
|
|
March 31, 2018
|
|
December 31, 2017
|
||||
Buildings and improvements
|
|
$
|
253,649
|
|
|
$
|
233,407
|
|
Furniture, fixtures and equipment
|
|
15,719
|
|
|
14,537
|
|
||
Less: accumulated depreciation
|
|
(9,593
|
)
|
|
(7,592
|
)
|
||
Buildings, furniture, fixtures and equipment, net of accumulated depreciation
|
|
259,775
|
|
|
240,352
|
|
||
Land
|
|
17,201
|
|
|
16,641
|
|
||
Goodwill
|
|
5,840
|
|
|
5,840
|
|
||
Net working capital
(1)
|
|
16,369
|
|
|
18,994
|
|
||
Total real estate assets
|
|
$
|
299,185
|
|
|
$
|
281,827
|
|
(1)
|
Net working capital primarily includes
$14.7 million
and
$16.1 million
of cash and cash equivalents and
$3.4 million
and
$2.8 million
of rent receivable recorded in other assets on the consolidated balances sheets as of
March 31, 2018 and December 31, 2017
, respectively.
|
|
|
For the Three Months Ended March 31,
|
||||||
|
|
2018
|
|
2017
|
||||
Beginning balance
|
|
$
|
186,500
|
|
|
$
|
66,527
|
|
Debt issued and assumed, net of deferred financing costs
|
|
15,938
|
|
|
19,581
|
|
||
Amortization of deferred financing costs
|
|
58
|
|
|
193
|
|
||
Principal repayments
|
|
(510
|
)
|
|
(93
|
)
|
||
Ending balance
|
|
$
|
201,986
|
|
|
$
|
86,208
|
|
|
|
For the Three Months Ended March 31,
|
||||||
|
|
2018
|
|
2017
|
||||
Lease income
|
|
$
|
5,706
|
|
|
$
|
2,253
|
|
Rental income
|
|
2,054
|
|
|
1,062
|
|
||
Healthcare real estate income
|
|
7,760
|
|
|
3,315
|
|
||
|
|
|
|
|
||||
Interest expense
|
|
2,089
|
|
|
1,173
|
|
||
Depreciation
|
|
2,001
|
|
|
771
|
|
||
Tenant expenses
|
|
1,425
|
|
|
709
|
|
||
Other
|
|
280
|
|
|
—
|
|
||
Healthcare real estate expense
|
|
5,795
|
|
|
2,653
|
|
||
Net healthcare investment income
|
|
$
|
1,964
|
|
|
$
|
662
|
|
|
|
March 31, 2018
|
||
2018
|
|
$
|
15,301
|
|
2019
|
|
20,764
|
|
|
2020
|
|
21,191
|
|
|
2021
|
|
21,627
|
|
|
2022
|
|
22,073
|
|
|
Thereafter
|
|
193,233
|
|
|
Total
|
|
$
|
294,189
|
|
|
|
March 31, 2018
|
|
December 31, 2017
|
||||||||||||||
|
|
|
|
Weighted Average
|
|
|
|
Weighted Average
|
||||||||||
Collateral Type
|
|
Borrowings
Outstanding |
|
Interest Rate
|
|
Days
to Maturity |
|
Borrowings
Outstanding |
|
Interest Rate
|
|
Days
to Maturity |
||||||
Agency securities
|
|
$
|
3,170,784
|
|
|
1.78
|
%
|
|
106
|
|
$
|
3,307,662
|
|
|
1.54
|
%
|
|
114
|
Non-agency securities
|
|
569,380
|
|
|
2.93
|
%
|
|
18
|
|
556,057
|
|
|
2.72
|
%
|
|
24
|
||
U.S. Treasury securities
|
|
3,272
|
|
|
1.65
|
%
|
|
1
|
|
—
|
|
|
N/A
|
|
|
N/A
|
||
Total repurchase agreements
|
|
$
|
3,743,436
|
|
|
1.96
|
%
|
|
92
|
|
$
|
3,863,719
|
|
|
1.71
|
%
|
|
101
|
|
|
March 31, 2018
|
|
December 31, 2017
|
||||||||||||||
|
|
|
|
Weighted Average
|
|
|
|
Weighted Average
|
||||||||||
|
|
Borrowings
Outstanding
|
|
Interest Rate
|
|
Days
to Maturity |
|
Borrowings
Outstanding
|
|
Interest Rate
|
|
Days
to Maturity |
||||||
≤ 1 month
|
|
$
|
1,584,501
|
|
|
2.09
|
%
|
|
14
|
|
$
|
1,341,712
|
|
|
1.91
|
%
|
|
17
|
> 1 to ≤ 2 months
|
|
955,061
|
|
|
1.80
|
%
|
|
43
|
|
1,334,493
|
|
|
1.55
|
%
|
|
40
|
||
> 2 to ≤ 3 months
|
|
342,533
|
|
|
1.95
|
%
|
|
78
|
|
295,204
|
|
|
1.76
|
%
|
|
76
|
||
> 3 to ≤ 6 months
|
|
510,378
|
|
|
1.71
|
%
|
|
155
|
|
334,372
|
|
|
1.51
|
%
|
|
123
|
||
> 6 to ≤ 12 months
|
|
85,963
|
|
|
2.04
|
%
|
|
301
|
|
292,938
|
|
|
1.57
|
%
|
|
256
|
||
> 12 months
|
|
265,000
|
|
|
2.18
|
%
|
|
568
|
|
265,000
|
|
|
1.80
|
%
|
|
658
|
||
Total repurchase agreements
|
|
$
|
3,743,436
|
|
|
1.96
|
%
|
|
92
|
|
$
|
3,863,719
|
|
|
1.71
|
%
|
|
101
|
|
|
March 31, 2018
|
|
December 31, 2017
|
||||
Derivative assets:
|
|
|
|
|
||||
Interest rate swaps
|
|
$
|
7,195
|
|
|
$
|
4,894
|
|
Interest rate swaptions
|
|
12,820
|
|
|
6,728
|
|
||
TBA securities
|
|
9,711
|
|
|
3,090
|
|
||
Derivative assets, at fair value
|
|
$
|
29,726
|
|
|
$
|
14,712
|
|
|
|
|
|
|
||||
Derivative liabilities:
|
|
|
|
|
||||
TBA securities
|
|
—
|
|
|
1,339
|
|
||
Credit default swaps
|
|
—
|
|
|
3,115
|
|
||
Derivative liabilities, at fair value
|
|
$
|
—
|
|
|
$
|
4,454
|
|
|
For the Three Months Ended March 31,
|
||||||||||||||||||
|
2018
|
|
2017
|
||||||||||||||||
|
Realized Gain on Periodic Settlements of Interest Rate Swaps, net
|
Realized Gain (Loss)
on Other Derivatives and Securities, net |
Unrealized Gain
(Loss) on Other Derivatives and Securities, net |
|
Realized Loss on Periodic Settlements of Interest Rate Swaps, net
|
Realized Gain (Loss)
on Other Derivatives and Securities, net |
Unrealized Gain (Loss) on Other Derivatives and Securities, net
|
||||||||||||
Interest rate swaps
|
$
|
358
|
|
$
|
47,929
|
|
$
|
2,120
|
|
|
$
|
(2,660
|
)
|
$
|
26,021
|
|
$
|
(21,830
|
)
|
Interest rate swaptions
|
—
|
|
—
|
|
5,322
|
|
|
—
|
|
—
|
|
(428
|
)
|
||||||
TBA securities
|
—
|
|
(43,145
|
)
|
7,959
|
|
|
—
|
|
(24,290
|
)
|
29,510
|
|
||||||
Short sales of U.S. Treasuries
|
—
|
|
(389
|
)
|
16,503
|
|
|
—
|
|
251
|
|
(9,641
|
)
|
||||||
Credit default swaps
|
—
|
|
(1,648
|
)
|
1,528
|
|
|
—
|
|
(43
|
)
|
(457
|
)
|
||||||
Other
|
—
|
|
(11
|
)
|
25
|
|
|
—
|
|
228
|
|
7
|
|
||||||
Total
|
$
|
358
|
|
$
|
2,736
|
|
$
|
33,457
|
|
|
$
|
(2,660
|
)
|
$
|
2,167
|
|
$
|
(2,839
|
)
|
|
December 31, 2017
Notional Amount |
|
Additions/ Long Positions
|
|
Expirations/
Terminations/ Short Positions
|
|
March 31, 2018
Notional Amount |
||||||
Interest rate swaps
|
$
|
3,530,000
|
|
|
100,000
|
|
|
—
|
|
|
$
|
3,630,000
|
|
Interest rate swaptions
|
$
|
425,000
|
|
|
75,000
|
|
|
—
|
|
|
$
|
500,000
|
|
TBA securities
|
$
|
1,704,386
|
|
|
5,057,110
|
|
|
(5,174,652
|
)
|
|
$
|
1,586,844
|
|
U.S. Treasuries
|
$
|
—
|
|
|
119,500
|
|
|
(94,500
|
)
|
|
$
|
25,000
|
|
Short sales of U.S. Treasuries
|
$
|
(846,700
|
)
|
|
49,500
|
|
|
(60,500
|
)
|
|
$
|
(857,700
|
)
|
Credit default swaps
|
$
|
48,000
|
|
|
—
|
|
|
(48,000
|
)
|
|
$
|
—
|
|
|
December 31, 2016
Notional Amount |
|
Additions/ Long Positions
|
|
Expirations/
Terminations/ Short Positions
|
|
March 31, 2017
Notional Amount |
||||||
Interest rate swaps
|
$
|
2,975,000
|
|
|
75,000
|
|
|
(75,000
|
)
|
|
$
|
2,975,000
|
|
Interest rate swaptions
|
$
|
150,000
|
|
|
—
|
|
|
—
|
|
|
$
|
150,000
|
|
TBA securities
|
$
|
886,042
|
|
|
7,928,617
|
|
|
(6,774,908
|
)
|
|
$
|
2,039,751
|
|
U.S. Treasuries
|
$
|
21,000
|
|
|
22,500
|
|
|
(43,500
|
)
|
|
$
|
—
|
|
Short sales of U.S. Treasuries
|
$
|
(511,000
|
)
|
|
318,500
|
|
|
(1,172,000
|
)
|
|
$
|
(1,364,500
|
)
|
Credit default swaps
|
$
|
49,000
|
|
|
—
|
|
|
(500
|
)
|
|
$
|
48,500
|
|
|
|
March 31, 2018
|
|
December 31, 2017
|
||||||||||||||||||||
|
|
Notional
Amount |
|
Weighted Average
|
|
Notional
Amount |
|
Weighted Average
|
||||||||||||||||
Current Maturity Date
(1)
|
|
|
Fixed
Pay Rate (2) |
|
Receive
Rate (3) |
|
Maturity
(Years)
|
|
|
Fixed
Pay Rate (2) |
|
Receive
Rate (3) |
|
Maturity
(Years)
|
||||||||||
≤ 3 years
|
|
$
|
1,600,000
|
|
|
1.31
|
%
|
|
1.90
|
%
|
|
1.2
|
|
$
|
1,500,000
|
|
|
1.26
|
%
|
|
1.46
|
%
|
|
1.3
|
> 3 to ≤ 5 years
|
|
935,000
|
|
|
1.77
|
%
|
|
1.94
|
%
|
|
3.9
|
|
985,000
|
|
|
1.79
|
%
|
|
1.47
|
%
|
|
4.0
|
||
> 5 to ≤ 7 years
|
|
400,000
|
|
|
1.98
|
%
|
|
1.79
|
%
|
|
5.4
|
|
350,000
|
|
|
1.78
|
%
|
|
1.40
|
%
|
|
5.7
|
||
> 7 years
|
|
695,000
|
|
|
2.26
|
%
|
|
1.96
|
%
|
|
9.6
|
|
695,000
|
|
|
2.26
|
%
|
|
1.47
|
%
|
|
9.9
|
||
Total
|
|
$
|
3,630,000
|
|
|
1.68
|
%
|
|
1.91
|
%
|
|
4.0
|
|
$
|
3,530,000
|
|
|
1.65
|
%
|
|
1.46
|
%
|
|
4.2
|
(1)
|
Includes swaps with an aggregate notional of
$0.2 billion
and
$0.4 billion
with deferred start dates averaging
0.0 years
and
0.1 years
from
March 31, 2018 and December 31, 2017
, respectively.
|
(2)
|
Excluding forward starting swaps, the weighted average pay rate was
1.64%
and
1.58%
as of
March 31, 2018 and December 31, 2017
, respectively.
|
(3)
|
Weighted average receive rate excludes impact of forward starting interest rate swaps.
|
March 31, 2018
|
|||||||||||||||||||
|
|
Option
|
|
Underlying Swap
|
|||||||||||||||
Current Option Expiration Date
|
|
Cost
|
|
Fair Value
|
|
Weighted Average Years to Expiration
|
|
Notional Amount
|
|
Pay Rate
|
|
Weighted Average Term (Years)
|
|||||||
|
|
|
|
|
|
||||||||||||||
≤ 12 months
|
|
$
|
2,341
|
|
|
$
|
3,979
|
|
|
0.7
|
|
$
|
200,000
|
|
|
2.73
|
%
|
|
8.4
|
>12 to ≤ 24 months
|
|
2,623
|
|
|
3,077
|
|
|
1.2
|
|
125,000
|
|
|
2.86
|
%
|
|
8.4
|
|||
> 24 months
|
|
7,951
|
|
|
5,764
|
|
|
3.2
|
|
175,000
|
|
|
2.87
|
%
|
|
8.7
|
|||
Total / weighted average
|
|
$
|
12,915
|
|
|
$
|
12,820
|
|
|
1.7
|
|
$
|
500,000
|
|
|
2.81
|
%
|
|
8.5
|
December 31, 2017
|
|||||||||||||||||||
|
|
Option
|
|
Underlying Swap
|
|||||||||||||||
Current Option Expiration Date
|
|
Cost
|
|
Fair Value
|
|
Weighted Average Years to Expiration
|
|
Notional Amount
|
|
Pay Rate
|
|
Weighted Average Term (Years)
|
|||||||
|
|
|
|
|
|
||||||||||||||
< 12 months
|
|
$
|
2,111
|
|
|
$
|
1,621
|
|
|
0.9
|
|
$
|
175,000
|
|
|
2.71
|
%
|
|
8.6
|
>12 to ≤ 24 months
|
|
2,083
|
|
|
1,400
|
|
|
1.5
|
|
75,000
|
|
|
2.73
|
%
|
|
10.0
|
|||
> 24 months
|
|
7,951
|
|
|
3,707
|
|
|
3.4
|
|
175,000
|
|
|
2.87
|
%
|
|
8.9
|
|||
Total / weighted average
|
|
$
|
12,145
|
|
|
$
|
6,728
|
|
|
2.0
|
|
$
|
425,000
|
|
|
2.78
|
%
|
|
8.9
|
|
|
March 31, 2018
|
|
December 31, 2017
|
||||||||||||
Purchase and Sale Contracts for TBA Securities
|
|
Notional
Amount
(1)
|
|
Fair
Value
(2)
|
|
Notional
Amount
(1)
|
|
Fair
Value
(2)
|
||||||||
TBA assets:
|
|
|
|
|
|
|
|
|
||||||||
Purchase of TBA securities
|
|
$
|
1,586,844
|
|
|
$
|
9,711
|
|
|
$
|
1,386,416
|
|
|
$
|
3,089
|
|
Sale of TBA securities
|
|
—
|
|
|
—
|
|
|
(1,200
|
)
|
|
1
|
|
||||
Total TBA assets
|
|
1,586,844
|
|
|
9,711
|
|
|
1,385,216
|
|
|
3,090
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
TBA liabilities:
|
|
|
|
|
|
|
|
|
||||||||
Purchase of TBA securities
|
|
—
|
|
|
—
|
|
|
319,170
|
|
|
(1,339
|
)
|
||||
Sale of TBA securities
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
Total TBA liabilities
|
|
—
|
|
|
—
|
|
|
319,170
|
|
|
(1,339
|
)
|
||||
Total net TBA
|
|
$
|
1,586,844
|
|
|
$
|
9,711
|
|
|
$
|
1,704,386
|
|
|
$
|
1,751
|
|
(1)
|
Notional amount represents the par value or principal balance of the underlying agency security.
|
(2)
|
Fair value represents the current market value of the agency RMBS underlying the TBA contract as of period end, less the forward price to be paid for the underlying agency RMBS.
|
|
|
Gross Amounts of Recognized Assets
|
|
Gross Amounts Offset in the Consolidated Balance Sheets
|
|
Net Amounts Presented
in the Consolidated Balance Sheets
|
|
Gross Amounts Not Offset in the Consolidated Balance Sheets
|
|
|
||||||||||||||
|
|
|
|
|
Financial Instruments
|
|
Collateral Received
(1)
|
|
Net Amount
|
|||||||||||||||
March 31, 2018
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Interest rate swaps and swaptions
(2)
|
|
$
|
20,015
|
|
|
$
|
—
|
|
|
$
|
20,015
|
|
|
$
|
—
|
|
|
$
|
(16,891
|
)
|
|
$
|
3,124
|
|
TBA
|
|
9,711
|
|
|
—
|
|
|
9,711
|
|
|
—
|
|
|
—
|
|
|
9,711
|
|
||||||
Receivable under reverse repurchase agreements
|
|
836,901
|
|
|
—
|
|
|
836,901
|
|
|
(666,306
|
)
|
|
(170,595
|
)
|
|
—
|
|
||||||
Total
|
|
$
|
866,627
|
|
|
$
|
—
|
|
|
$
|
866,627
|
|
|
$
|
(666,306
|
)
|
|
$
|
(187,486
|
)
|
|
$
|
12,835
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
December 31, 2017
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Interest rate swaps and swaptions
(2)
|
|
$
|
11,622
|
|
|
$
|
—
|
|
|
$
|
11,622
|
|
|
$
|
—
|
|
|
$
|
(5,642
|
)
|
|
$
|
5,980
|
|
TBA
|
|
3,090
|
|
|
—
|
|
|
3,090
|
|
|
(1,339
|
)
|
|
—
|
|
|
1,751
|
|
||||||
Receivable under reverse repurchase agreements
|
|
843,130
|
|
|
—
|
|
|
843,130
|
|
|
(725,319
|
)
|
|
(117,811
|
)
|
|
—
|
|
||||||
Total
|
|
$
|
857,842
|
|
|
$
|
—
|
|
|
$
|
857,842
|
|
|
$
|
(726,658
|
)
|
|
$
|
(123,453
|
)
|
|
$
|
7,731
|
|
|
|
Gross Amounts of Recognized Liabilities
|
|
Gross Amounts Offset in the Consolidated Balance Sheets
|
|
Net Amounts Presented
in the Consolidated Balance Sheets
|
|
Gross Amounts Not Offset in the Consolidated Balance Sheets
|
|
|
||||||||||||||
|
|
|
|
|
Financial Instruments
|
|
Collateral Pledged
(1)
|
|
Net Amount
|
|||||||||||||||
March 31, 2018
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Repurchase agreements
|
|
$
|
3,743,436
|
|
|
$
|
—
|
|
|
$
|
3,743,436
|
|
|
$
|
(666,306
|
)
|
|
$
|
(3,077,130
|
)
|
|
$
|
—
|
|
Total
|
|
$
|
3,743,436
|
|
|
$
|
—
|
|
|
$
|
3,743,436
|
|
|
$
|
(666,306
|
)
|
|
$
|
(3,077,130
|
)
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
December 31, 2017
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
TBA
|
|
$
|
1,339
|
|
|
$
|
—
|
|
|
$
|
1,339
|
|
|
$
|
(1,339
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
Repurchase agreements
|
|
3,863,719
|
|
|
—
|
|
|
3,863,719
|
|
|
(725,319
|
)
|
|
(3,138,400
|
)
|
|
—
|
|
||||||
Total
|
|
$
|
3,865,058
|
|
|
$
|
—
|
|
|
$
|
3,865,058
|
|
|
$
|
(726,658
|
)
|
|
$
|
(3,138,400
|
)
|
|
$
|
—
|
|
(1)
|
Includes cash and securities received / pledged as collateral, at fair value. Amounts presented are limited to collateral pledged sufficient to reduce the net amount to zero on a counterparty by counterparty basis, as applicable. Refer to Notes 3 and 4 for additional information regarding assets pledged.
|
(2)
|
Reported under derivative assets / liabilities, at fair value in the accompanying consolidated balance sheets. Refer to Note 8 for a reconciliation of derivative assets / liabilities, at fair value to their sub-components.
|
•
|
Level 1 Inputs - Quoted prices (unadjusted) for identical unrestricted assets and liabilities in active markets that are accessible at the measurement date.
|
•
|
Level 2 Inputs - Quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable.
|
•
|
Level 3 Inputs - Significant unobservable market inputs that are supported by little or no market activity. The unobservable inputs represent the assumptions that market participants would use to price the assets and liabilities.
|
|
|
March 31, 2018
|
||||||||||||||
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
||||||||
Assets
|
|
|
|
|
|
|
|
|
||||||||
Agency securities
|
|
$
|
—
|
|
|
$
|
3,660,403
|
|
|
$
|
—
|
|
|
$
|
3,660,403
|
|
Non-agency securities
|
|
—
|
|
|
833,681
|
|
|
—
|
|
|
833,681
|
|
||||
U.S. Treasury securities
|
|
24,924
|
|
|
—
|
|
|
—
|
|
|
24,924
|
|
||||
Derivative assets
|
|
—
|
|
|
29,726
|
|
|
—
|
|
|
29,726
|
|
||||
Total
|
|
$
|
24,924
|
|
|
$
|
4,523,810
|
|
|
$
|
—
|
|
|
$
|
4,548,734
|
|
|
|
|
|
|
|
|
|
|
||||||||
Liabilities
|
|
|
|
|
|
|
|
|
||||||||
Obligation to return securities borrowed under reverse repurchase agreements
|
|
824,688
|
|
|
—
|
|
|
—
|
|
|
824,688
|
|
||||
Total
|
|
$
|
824,688
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
824,688
|
|
|
|
December 31, 2017
|
||||||||||||||
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
||||||||
Assets
|
|
|
|
|
|
|
|
|
||||||||
Agency securities
|
|
$
|
—
|
|
|
$
|
3,758,181
|
|
|
$
|
—
|
|
|
$
|
3,758,181
|
|
Non-agency securities
|
|
—
|
|
|
872,084
|
|
|
—
|
|
|
872,084
|
|
||||
Derivative assets
|
|
—
|
|
|
14,712
|
|
|
—
|
|
|
14,712
|
|
||||
Total
|
|
$
|
—
|
|
|
$
|
4,644,977
|
|
|
$
|
—
|
|
|
$
|
4,644,977
|
|
|
|
|
|
|
|
|
|
|
||||||||
Liabilities
|
|
|
|
|
|
|
|
|
||||||||
Derivative liabilities
|
|
$
|
—
|
|
|
$
|
4,454
|
|
|
$
|
—
|
|
|
$
|
4,454
|
|
Obligation to return securities borrowed under reverse repurchase agreements
|
|
830,776
|
|
|
—
|
|
|
—
|
|
|
830,776
|
|
||||
Total
|
|
$
|
830,776
|
|
|
$
|
4,454
|
|
|
$
|
—
|
|
|
$
|
835,230
|
|
|
|
March 31, 2018
|
|
December 31, 2017
|
||||
Servicing advances
|
|
$
|
—
|
|
|
$
|
324
|
|
Prepaid expenses
|
|
1,595
|
|
|
1,993
|
|
||
Accounts receivable
|
|
2,033
|
|
|
5,682
|
|
||
Goodwill
|
|
5,840
|
|
|
5,840
|
|
||
Other
|
|
6,557
|
|
|
9,403
|
|
||
Total other assets
|
|
$
|
16,025
|
|
|
$
|
23,242
|
|
|
|
March 31, 2018
|
|
December 31, 2017
|
||||
Cash collateral held
|
|
$
|
16,992
|
|
|
$
|
5,642
|
|
Due to manager
|
|
1,473
|
|
|
1,451
|
|
||
Accrued interest
|
|
15,181
|
|
|
12,547
|
|
||
Other accounts payable and accrued expenses
|
|
11,258
|
|
|
13,952
|
|
||
Total accounts payable and other accrued liabilities
|
|
$
|
44,904
|
|
|
$
|
33,592
|
|
•
|
$9.82 in cash and 0.9519 shares of Annaly common stock (the “Mixed Consideration Option”);
|
•
|
$19.65 in cash (the “Cash Consideration Option”); or
|
•
|
1.9037 shares of Annaly common stock (the “Stock Consideration Option”).
|
•
|
Financial Condition
|
•
|
Results of Operations
|
•
|
Liquidity and Capital Resources
|
•
|
Off-Balance Sheet Arrangements
|
•
|
Forward-Looking Statements
|
Interest Rate / Security
(1)
|
|
March
31, 2018
|
|
December 31, 2017
|
|
September 30, 2017
|
|
June 30, 2017
|
|
March 31, 2017
|
||||||||||
LIBOR:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
1-Month
|
|
1.88
|
%
|
|
1.56
|
%
|
|
1.23
|
%
|
|
1.22
|
%
|
|
0.98
|
%
|
|||||
3-Month
|
|
2.31
|
%
|
|
1.69
|
%
|
|
1.33
|
%
|
|
1.30
|
%
|
|
1.15
|
%
|
|||||
U.S. Treasury Securities:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
2-Year U.S. Treasury
|
|
2.27
|
%
|
|
1.89
|
%
|
|
1.48
|
%
|
|
1.38
|
%
|
|
1.26
|
%
|
|||||
5-Year U.S. Treasury
|
|
2.57
|
%
|
|
2.21
|
%
|
|
1.93
|
%
|
|
1.89
|
%
|
|
1.93
|
%
|
|||||
10-Year U.S. Treasury
|
|
2.74
|
%
|
|
2.41
|
%
|
|
2.33
|
%
|
|
2.30
|
%
|
|
2.39
|
%
|
|||||
Interest Rate Swap Rates:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
2-Year Swap Rate
|
|
2.58
|
%
|
|
2.08
|
%
|
|
1.73
|
%
|
|
1.61
|
%
|
|
1.62
|
%
|
|||||
5-Year Swap Rate
|
|
2.71
|
%
|
|
2.24
|
%
|
|
2.00
|
%
|
|
1.95
|
%
|
|
2.06
|
%
|
|||||
10-Year Swap Rate
|
|
2.78
|
%
|
|
2.4
|
%
|
|
2.28
|
%
|
|
2.27
|
%
|
|
2.39
|
%
|
|||||
30-Year Fixed Rate Agency Price:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
3.5%
|
|
$
|
100.20
|
|
|
$
|
102.70
|
|
|
$
|
103.09
|
|
|
$
|
102.70
|
|
|
$
|
102.29
|
|
4.0%
|
|
$
|
102.61
|
|
|
$
|
104.59
|
|
|
$
|
105.27
|
|
|
$
|
105.12
|
|
|
$
|
104.90
|
|
4.5%
|
|
$
|
104.70
|
|
|
$
|
106.40
|
|
|
$
|
107.33
|
|
|
$
|
107.27
|
|
|
$
|
107.24
|
|
15-Year Fixed Rate Agency Price:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
2.5%
|
|
$
|
97.98
|
|
|
$
|
99.88
|
|
|
$
|
100.69
|
|
|
$
|
100.53
|
|
|
$
|
100.03
|
|
3.0%
|
|
$
|
99.88
|
|
|
$
|
101.88
|
|
|
$
|
102.75
|
|
|
$
|
102.64
|
|
|
$
|
102.51
|
|
3.5%
|
|
$
|
101.94
|
|
|
$
|
103.23
|
|
|
$
|
104.14
|
|
|
$
|
104.06
|
|
|
$
|
104.06
|
|
(1)
|
Price information is for generic instruments only and is not reflective of our specific portfolio holdings. Price information can vary by source. Prices in the table above were obtained from a combination of Bloomberg and dealer indications. Interest rates were obtained from Bloomberg.
|
Specified Mortgage Pool Pay-ups over Generic TBA Price
(1)(2)
|
|
March 31,
2018
|
|
December 31, 2017
|
|
September 30, 2017
|
|
June 30, 2017
|
|
March 31, 2017
|
||||||||||
30-Year Lower Loan Balance
(3)
:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
3.0%
|
|
$
|
0.41
|
|
|
$
|
0.41
|
|
|
$
|
0.45
|
|
|
$
|
0.41
|
|
|
$
|
0.38
|
|
3.5%
|
|
$
|
0.56
|
|
|
$
|
0.81
|
|
|
$
|
0.89
|
|
|
$
|
0.83
|
|
|
$
|
0.72
|
|
4.0%
|
|
$
|
1.03
|
|
|
$
|
1.69
|
|
|
$
|
1.69
|
|
|
$
|
1.47
|
|
|
$
|
1.20
|
|
30-Year HARP
(4)
:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
3.5%
|
|
$
|
—
|
|
|
$
|
0.03
|
|
|
$
|
0.16
|
|
|
$
|
0.16
|
|
|
$
|
0.16
|
|
4.0%
|
|
$
|
0.05
|
|
|
$
|
0.17
|
|
|
$
|
0.50
|
|
|
$
|
0.50
|
|
|
$
|
0.47
|
|
(1)
|
Source: Bloomberg and dealer indications.
|
(2)
|
“Pay-ups” represent the value of the price premium of specified securities over generic TBA pools. The table above includes pay-ups for newly originated specified pools. Price information is provided for information only and is not meant to be reflective of our specific portfolio holdings. Prices can vary materially depending on the source.
|
(3)
|
Lower loan balance pay-ups for pools with original loan balances from $85,000 to $110,000.
|
(4)
|
HARP pay-ups for pools backed by 100% refinance loans with original loan-to-value ratios between 95% and 100%.
|
|
|
March 31, 2018
|
|
December 31, 2017
|
||||
Notional fair value of securities investments:
|
|
|
|
|
||||
Agency RMBS, at fair value
|
|
$
|
3,660,403
|
|
|
$
|
3,758,181
|
|
Non-agency securities, at fair value
|
|
833,681
|
|
|
872,084
|
|
||
Subtotal
|
|
4,494,084
|
|
|
4,630,265
|
|
||
TBA notional fair value
|
|
1,582,747
|
|
|
1,733,152
|
|
||
Total securities investments notional fair value
|
|
$
|
6,076,831
|
|
|
$
|
6,363,417
|
|
Agency and non-agency securities funding
|
|
$
|
3,743,436
|
|
|
$
|
3,863,719
|
|
At risk securities leverage
|
|
6.2x
|
|
|
6.2x
|
|
||
|
|
|
|
|
||||
Healthcare investments:
|
|
|
|
|
||||
Real estate related assets, including net working capital
|
|
$
|
299,185
|
|
|
$
|
281,827
|
|
Notes payable, net of deferred financing costs
|
|
$
|
201,986
|
|
|
$
|
186,500
|
|
Healthcare leverage
|
|
2.1x
|
|
|
2.0x
|
|
||
|
|
|
|
|
||||
Total assets
|
|
$
|
5,857,808
|
|
|
$
|
5,953,036
|
|
Total liabilities
|
|
$
|
4,897,212
|
|
|
$
|
4,947,414
|
|
Total stockholders' equity
|
|
$
|
959,797
|
|
|
$
|
1,005,107
|
|
Net asset value per common share
|
|
$
|
19.76
|
|
|
$
|
20.75
|
|
|
|
March 31, 2018
|
||||||||||||||||
|
|
Fair Value
|
|
Amortized Cost Basis
|
|
Par Value
|
|
Weighted Average
|
||||||||||
Coupon
|
|
Yield
(1)
|
||||||||||||||||
Fannie Mae
|
|
$
|
2,436,815
|
|
|
$
|
2,511,459
|
|
|
$
|
2,393,236
|
|
|
3.61
|
%
|
|
2.82
|
%
|
Freddie Mac
|
|
1,223,588
|
|
|
1,260,013
|
|
|
1,196,372
|
|
|
3.73
|
%
|
|
2.96
|
%
|
|||
Agency RMBS total
|
|
3,660,403
|
|
|
3,771,472
|
|
|
3,589,608
|
|
|
3.65
|
%
|
|
2.87
|
%
|
|||
Non-agency securities
|
|
833,681
|
|
|
744,562
|
|
|
874,844
|
|
|
3.91
|
%
|
|
6.92
|
%
|
|||
Total
|
|
$
|
4,494,084
|
|
|
$
|
4,516,034
|
|
|
$
|
4,464,452
|
|
|
3.70
|
%
|
|
3.54
|
%
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
December 31, 2017
|
||||||||||||||||
|
|
Fair Value
|
|
Amortized Cost Basis
|
|
Par Value
|
|
Weighted Average
|
||||||||||
|
|
Coupon
|
|
Yield
(1)
|
||||||||||||||
Fannie Mae
|
|
$
|
2,587,575
|
|
|
$
|
2,612,063
|
|
|
$
|
2,485,055
|
|
|
3.63
|
%
|
|
2.78
|
%
|
Freddie Mac
|
|
1,170,606
|
|
|
1,181,017
|
|
|
1,117,551
|
|
|
3.75
|
%
|
|
2.89
|
%
|
|||
Agency RMBS total
|
|
3,758,181
|
|
|
3,793,080
|
|
|
3,602,606
|
|
|
3.67
|
%
|
|
2.82
|
%
|
|||
Non-agency securities
|
|
872,084
|
|
|
779,629
|
|
|
911,707
|
|
|
3.73
|
%
|
|
6.59
|
%
|
|||
Total
|
|
$
|
4,630,265
|
|
|
$
|
4,572,709
|
|
|
$
|
4,514,313
|
|
|
3.67
|
%
|
|
3.44
|
%
|
(1)
|
The weighted average agency security yield incorporates an average future CPR assumption of
7.6%
and
8.4%
as of
March 31, 2018 and December 31, 2017
, respectively, based on forward rates. For non-agency securities, the weighted average yield is based on estimated cash flows that incorporate expected credit losses.
|
|
|
March 31, 2018
|
||||||||||||||||
|
|
Fair Value
|
|
Amortized Cost Basis
|
|
Par Value
|
|
Weighted Average
|
||||||||||
|
|
Yield
|
|
Projected CPR
|
||||||||||||||
Fixed rate
|
|
|
|
|
|
|
|
|
|
|
||||||||
≤ 15-year
|
|
|
|
|
|
|
|
|
|
|
||||||||
2.5%
|
|
$
|
29,360
|
|
|
$
|
29,844
|
|
|
$
|
29,832
|
|
|
2.44
|
%
|
|
8.8
|
%
|
3.0%
|
|
189,049
|
|
|
192,738
|
|
|
188,392
|
|
|
2.31
|
%
|
|
9.1
|
%
|
|||
3.5%
|
|
111,090
|
|
|
113,567
|
|
|
108,737
|
|
|
2.25
|
%
|
|
9.8
|
%
|
|||
4.0%
|
|
87,135
|
|
|
88,657
|
|
|
84,160
|
|
|
2.17
|
%
|
|
11.3
|
%
|
|||
4.5%
|
|
7,275
|
|
|
7,377
|
|
|
6,985
|
|
|
2.58
|
%
|
|
10.6
|
%
|
|||
≤ 15-year total
|
|
423,909
|
|
|
432,183
|
|
|
418,106
|
|
|
2.28
|
%
|
|
9.7
|
%
|
|||
20-year
|
|
|
|
|
|
|
|
|
|
|
||||||||
3.0%
|
|
52,079
|
|
|
53,829
|
|
|
52,370
|
|
|
2.35
|
%
|
|
10.6
|
%
|
|||
3.5%
|
|
62,984
|
|
|
63,651
|
|
|
61,829
|
|
|
2.82
|
%
|
|
9.8
|
%
|
|||
5.0%
|
|
823
|
|
|
850
|
|
|
771
|
|
|
2.13
|
%
|
|
14.8
|
%
|
|||
20-year total
|
|
115,886
|
|
|
118,330
|
|
|
114,970
|
|
|
2.60
|
%
|
|
10.2
|
%
|
|||
30-year
|
|
|
|
|
|
|
|
|
|
|
||||||||
3.0%
|
|
10,737
|
|
|
10,894
|
|
|
10,997
|
|
|
3.12
|
%
|
|
6.7
|
%
|
|||
3.5%
|
|
1,493,207
|
|
|
1,546,813
|
|
|
1,479,889
|
|
|
2.86
|
%
|
|
6.7
|
%
|
|||
4.0%
|
|
144,377
|
|
|
1,488,287
|
|
|
1,395,828
|
|
|
3.07
|
%
|
|
7.2
|
%
|
|||
4.5%
|
|
49,490
|
|
|
51,009
|
|
|
46,653
|
|
|
3.10
|
%
|
|
7.6
|
%
|
|||
30-year total
|
|
2,997,811
|
|
|
3,097,003
|
|
|
2,933,367
|
|
|
2.96
|
%
|
|
6.9
|
%
|
|||
Pass through agency RMBS
|
|
3,537,606
|
|
|
3,647,516
|
|
|
3,466,443
|
|
|
2.87
|
%
|
|
7.4
|
%
|
|||
Agency CMO and other
|
|
49,722
|
|
|
51,029
|
|
|
49,569
|
|
|
2.81
|
%
|
|
1.9
|
%
|
|||
Total fixed-rate agency RMBS
|
|
3,587,328
|
|
|
3,698,545
|
|
|
3,516,012
|
|
|
2.87
|
%
|
|
7.3
|
%
|
|||
Adjustable rate agency RMBS
|
|
73,075
|
|
|
72,927
|
|
|
73,596
|
|
|
2.87
|
%
|
|
20.2
|
%
|
|||
Total agency RMBS
|
|
$
|
3,660,403
|
|
|
$
|
3,771,472
|
|
|
$
|
3,589,608
|
|
|
2.87
|
%
|
|
7.6
|
%
|
|
|
December 31, 2017
|
||||||||||||||||
|
|
Fair Value
|
|
Amortized Cost Basis
|
|
Par Value
|
|
Weighted Average
|
||||||||||
|
|
Yield
|
|
Projected CPR
|
||||||||||||||
Fixed rate
|
|
|
|
|
|
|
|
|
|
|
||||||||
≤ 15-year
|
|
|
|
|
|
|
|
|
|
|
||||||||
2.5%
|
|
$
|
31,438
|
|
|
$
|
31,421
|
|
|
$
|
31,405
|
|
|
2.44
|
%
|
|
8.8
|
%
|
3.0%
|
|
169,991
|
|
|
171,384
|
|
|
166,572
|
|
|
2.17
|
%
|
|
9.4
|
%
|
|||
3.5%
|
|
141,410
|
|
|
142,448
|
|
|
136,503
|
|
|
2.30
|
%
|
|
10.4
|
%
|
|||
4.0%
|
|
93,679
|
|
|
94,528
|
|
|
89,635
|
|
|
2.17
|
%
|
|
11.4
|
%
|
|||
4.5%
|
|
7,841
|
|
|
7,883
|
|
|
7,457
|
|
|
2.58
|
%
|
|
10.8
|
%
|
|||
≤ 15-year total
|
|
444,359
|
|
|
447,664
|
|
|
431,572
|
|
|
2.24
|
%
|
|
10.1
|
%
|
|||
20-year
|
|
|
|
|
|
|
|
|
|
|
||||||||
3.0%
|
|
55,360
|
|
|
55,876
|
|
|
54,349
|
|
|
2.34
|
%
|
|
10.8
|
%
|
|||
3.5%
|
|
67,410
|
|
|
66,699
|
|
|
64,799
|
|
|
2.82
|
%
|
|
10.2
|
%
|
|||
5.0%
|
|
1,116
|
|
|
1,135
|
|
|
1,038
|
|
|
2.20
|
%
|
|
16.7
|
%
|
|||
20-year total
|
|
123,886
|
|
|
123,710
|
|
|
120,186
|
|
|
2.60
|
%
|
|
10.5
|
%
|
|||
30-year
|
|
|
|
|
|
|
|
|
|
|
||||||||
3.0%
|
|
11,077
|
|
|
10,966
|
|
|
11,071
|
|
|
3.12
|
%
|
|
7.1
|
%
|
|||
3.5%
|
|
1,396,687
|
|
|
1,417,768
|
|
|
1,350,308
|
|
|
2.78
|
%
|
|
7.2
|
%
|
|||
4.0%
|
|
1,601,321
|
|
|
1,612,878
|
|
|
1,514,426
|
|
|
3.02
|
%
|
|
8.4
|
%
|
|||
4.5%
|
|
52,203
|
|
|
52,637
|
|
|
48,208
|
|
|
3.07
|
%
|
|
8.2
|
%
|
|||
30-year total
|
|
3,061,288
|
|
|
3,094,249
|
|
|
2,924,013
|
|
|
2.91
|
%
|
|
7.9
|
%
|
|||
Pass through agency RMBS
|
|
3,629,533
|
|
|
3,665,623
|
|
|
3,475,771
|
|
|
2.82
|
%
|
|
8.2
|
%
|
|||
Agency CMO
|
|
51,535
|
|
|
51,662
|
|
|
50,115
|
|
|
2.81
|
%
|
|
2.1
|
%
|
|||
Total fixed-rate agency RMBS
|
|
3,681,068
|
|
|
3,717,285
|
|
|
3,525,886
|
|
|
2.82
|
%
|
|
8.1
|
%
|
|||
Adjustable rate agency RMBS
|
|
77,113
|
|
|
75,795
|
|
|
76,720
|
|
|
2.86
|
%
|
|
20.6
|
%
|
|||
Total agency RMBS
|
|
$
|
3,758,181
|
|
|
$
|
3,793,080
|
|
|
$
|
3,602,606
|
|
|
2.82
|
%
|
|
8.4
|
%
|
|
|
March 31, 2018
|
|||||||||||||||||||
|
|
Fair Value
|
|
Amortized Cost Basis
|
|
Par Value
|
|
Weighted Average
|
|||||||||||||
Coupon
|
|
Yield
|
|
Projected CPR
|
|||||||||||||||||
HARP
(1)
|
|
$
|
553,837
|
|
|
$
|
572,577
|
|
|
$
|
546,374
|
|
|
3.56
|
%
|
|
2.82
|
%
|
|
7.3
|
%
|
Lower loan balance
(2)
|
|
2,436,299
|
|
|
2,512,793
|
|
|
2,382,809
|
|
|
3.70
|
%
|
|
2.83
|
%
|
|
7.6
|
%
|
|||
Other
|
|
547,470
|
|
|
562,146
|
|
|
537,260
|
|
|
374.00
|
%
|
|
3.09
|
%
|
|
6.3
|
%
|
|||
Pass through agency RMBS
|
|
3,537,606
|
|
|
3,647,516
|
|
|
3,466,443
|
|
|
3.68
|
%
|
|
2.87
|
%
|
|
7.4
|
%
|
|||
Agency CMO and other
|
|
49,722
|
|
|
51,029
|
|
|
49,569
|
|
|
3.01
|
%
|
|
2.81
|
%
|
|
1.9
|
%
|
|||
Total fixed-rate agency RMBS
|
|
3,587,328
|
|
|
3,698,545
|
|
|
3,516,012
|
|
|
3.67
|
%
|
|
2.87
|
%
|
|
7.3
|
%
|
|||
Adjustable rate agency RMBS
|
|
73,075
|
|
|
72,927
|
|
|
73,596
|
|
|
2.54
|
%
|
|
2.87
|
%
|
|
20.2
|
%
|
|||
Total agency RMBS
|
|
$
|
3,660,403
|
|
|
$
|
3,771,472
|
|
|
$
|
3,589,608
|
|
|
3.65
|
%
|
|
2.87
|
%
|
|
7.6
|
%
|
(1)
|
HARP securities are defined as pools backed by 100% refinance loans with LTVs greater than or equal to 80%. Our HARP securities had a weighted average LTV of 124% and 128% for 15-year and 30-year securities, respectively, as of
March 31, 2018
. Includes $333.6 million of >105% LTV pools which are not deliverable into TBA securities.
|
(2)
|
Lower loan balance securities represent pools with maximum original loan balances less than or equal to $150,000. Our lower loan balance securities had a weighted average original loan balance of $101,655 and $106,829 for 15-year and 30-year securities, respectively, as of
March 31, 2018
.
|
|
|
December 31, 2017
|
|||||||||||||||||||
|
|
Fair Value
|
|
Amortized Cost Basis
|
|
Par Value
|
|
Weighted Average
|
|||||||||||||
Coupon
|
|
Yield
|
|
Projected CPR
|
|||||||||||||||||
HARP
(1)
|
|
$
|
588,217
|
|
|
$
|
594,839
|
|
|
$
|
568,348
|
|
|
3.56
|
%
|
|
2.81
|
%
|
|
8.0
|
%
|
Lower loan balance
(2)
|
|
2,303,047
|
|
|
2,330,173
|
|
|
2,200,991
|
|
|
3.72
|
%
|
|
2.76
|
%
|
|
8.1
|
%
|
|||
Other
|
|
738,269
|
|
|
740,611
|
|
|
706,432
|
|
|
3.79
|
%
|
|
2.99
|
%
|
|
8.9
|
%
|
|||
Pass through agency RMBS
|
|
3,629,533
|
|
|
3,665,623
|
|
|
3,475,771
|
|
|
3.70
|
%
|
|
2.82
|
%
|
|
8.2
|
%
|
|||
Agency CMO
|
|
51,535
|
|
|
51,662
|
|
|
50,115
|
|
|
3.01
|
%
|
|
2.81
|
%
|
|
2.1
|
%
|
|||
Total fixed-rate agency RMBS
|
|
3,681,068
|
|
|
3,717,285
|
|
|
3,525,886
|
|
|
3.69
|
%
|
|
2.82
|
%
|
|
8.1
|
%
|
|||
Adjustable rate agency RMBS
|
|
77,113
|
|
|
75,795
|
|
|
76,720
|
|
|
2.55
|
%
|
|
2.86
|
%
|
|
20.6
|
%
|
|||
Total agency RMBS
|
|
$
|
3,758,181
|
|
|
$
|
3,793,080
|
|
|
$
|
3,602,606
|
|
|
3.67
|
%
|
|
2.82
|
%
|
|
8.4
|
%
|
(1)
|
Our HARP securities had a weighted average LTV of 123% and 128% for 15-year and 30-year securities, respectively, as of
December 31, 2017
. Includes $355.0 million of >105% LTV pools which are not deliverable into TBA securities.
|
(2)
|
Our lower loan balance securities had a weighted average original loan balance of $98,996 and $106,244 for 15-year and 30-year securities, respectively, as of
December 31, 2017
.
|
|
|
March 31, 2018
|
||||||||||||||
|
|
Notional Amount
(1)
|
|
Cost Basis
(2)
|
|
Notional Market
Value (3) |
|
Net Carrying Value
(4)
|
||||||||
|
|
|
||||||||||||||
15- Year
|
|
|
|
|
|
|
|
|
||||||||
2.5%
|
|
$
|
47,500
|
|
|
$
|
46,029
|
|
|
$
|
46,519
|
|
|
$
|
490
|
|
3.0%
|
|
176,223
|
|
|
175,161
|
|
|
175,858
|
|
|
697
|
|
||||
3.5%
|
|
19,200
|
|
|
19,459
|
|
|
19,540
|
|
|
81
|
|
||||
Subtotal
|
|
242,923
|
|
|
240,649
|
|
|
241,917
|
|
|
1,268
|
|
||||
30-Year
|
|
|
|
|
|
|
|
|
||||||||
3.0%
|
|
470,660
|
|
|
454,464
|
|
|
458,784
|
|
|
4,320
|
|
||||
3.5%
|
|
588,406
|
|
|
586,186
|
|
|
589,301
|
|
|
3,115
|
|
||||
4.0%
|
|
263,009
|
|
|
268,923
|
|
|
269,872
|
|
|
949
|
|
||||
4.5%
|
|
21,846
|
|
|
22,814
|
|
|
22,873
|
|
|
59
|
|
||||
Subtotal
|
|
1,343,921
|
|
|
1,332,387
|
|
|
1,340,830
|
|
|
8,443
|
|
||||
Portfolio total
|
|
$
|
1,586,844
|
|
|
$
|
1,573,036
|
|
|
$
|
1,582,747
|
|
|
$
|
9,711
|
|
|
|
December 31, 2017
|
||||||||||||||
|
|
Notional Amount
(1)
|
|
Cost Basis
(2)
|
|
Notional Market
Value (3) |
|
Net Carrying Value
(4)
|
||||||||
|
|
|
||||||||||||||
15- Year
|
|
|
|
|
|
|
|
|
||||||||
2.5%
|
|
$
|
152,500
|
|
|
$
|
152,342
|
|
|
$
|
152,135
|
|
|
$
|
(207
|
)
|
3.0%
|
|
164,329
|
|
|
167,678
|
|
|
167,266
|
|
|
(412
|
)
|
||||
3.5%
|
|
(1,200
|
)
|
|
(1,240
|
)
|
|
(1,239
|
)
|
|
1
|
|
||||
Subtotal
|
|
315,629
|
|
|
318,780
|
|
|
318,162
|
|
|
(618
|
)
|
||||
30-Year
|
|
|
|
|
|
|
|
|
|
|||||||
3.0%
|
|
525,660
|
|
|
523,815
|
|
|
525,057
|
|
|
1,242
|
|
||||
3.5%
|
|
659,506
|
|
|
675,182
|
|
|
676,598
|
|
|
1,416
|
|
||||
4.0%
|
|
181,745
|
|
|
190,334
|
|
|
190,093
|
|
|
(241
|
)
|
||||
4.5%
|
|
21,846
|
|
|
23,290
|
|
|
23,242
|
|
|
(48
|
)
|
||||
Subtotal
|
|
1,388,757
|
|
|
1,412,621
|
|
|
1,414,990
|
|
|
2,369
|
|
||||
Portfolio total
|
|
$
|
1,704,386
|
|
|
$
|
1,731,401
|
|
|
$
|
1,733,152
|
|
|
$
|
1,751
|
|
(1)
|
Notional amount represents the par value or principal balance of the underlying agency RMBS.
|
(2)
|
Cost basis represents the forward price to be paid for the underlying agency RMBS.
|
(3)
|
Notional market value represents the current market value of the agency RMBS underlying the TBA contracts as of period end.
|
(4)
|
Net carrying value represents the difference between the market value of the TBA contract as of period end and the cost basis and is reported in derivative assets / (liabilities), at fair value in our consolidated balance sheets.
|
March 31, 2018
|
||||||||||||||||||||||||||||||
|
|
Fair
Value
|
|
Gross Unrealized
|
|
Amortized Cost
|
|
Premium (Discount)
|
|
Par/ Current Face
|
|
Weighted Average
|
||||||||||||||||||
Category
|
|
|
Gains
|
|
Losses
|
|
|
|
|
Coupon
(1)
|
|
Yield
|
||||||||||||||||||
Prime
|
|
$
|
139,841
|
|
|
$
|
9,529
|
|
|
$
|
(77
|
)
|
|
$
|
130,389
|
|
|
$
|
(13,262
|
)
|
|
$
|
143,651
|
|
|
3.86
|
%
|
|
5.89
|
%
|
CRT
|
|
300,338
|
|
|
16,465
|
|
|
(81
|
)
|
|
283,954
|
|
|
13,258
|
|
|
270,696
|
|
|
5.50
|
%
|
|
5.68
|
%
|
||||||
Alt-A
|
|
277,083
|
|
|
50,162
|
|
|
(628
|
)
|
|
227,549
|
|
|
(109,122
|
)
|
|
336,671
|
|
|
2.94
|
%
|
|
9.21
|
%
|
||||||
Option-ARM
|
|
84,683
|
|
|
12,790
|
|
|
—
|
|
|
71,893
|
|
|
(20,305
|
)
|
|
92,198
|
|
|
2.11
|
%
|
|
6.79
|
%
|
||||||
Subprime
|
|
13,337
|
|
|
873
|
|
|
—
|
|
|
12,464
|
|
|
(664
|
)
|
|
13,128
|
|
|
5.20
|
%
|
|
5.92
|
%
|
||||||
CMBS
|
|
18,399
|
|
|
171
|
|
|
(85
|
)
|
|
18,313
|
|
|
(187
|
)
|
|
18,500
|
|
|
5.68
|
%
|
|
6.04
|
%
|
||||||
Total
|
|
$
|
833,681
|
|
|
$
|
89,990
|
|
|
$
|
(871
|
)
|
|
$
|
744,562
|
|
|
$
|
(130,282
|
)
|
|
$
|
874,844
|
|
|
3.91
|
%
|
|
6.92
|
%
|
(1)
|
Coupon rates are floating, except for
$11.4 million
,
$5.6 million
,
$12.0 million
,
$13.3 million
,
$18.4 million
fair value of fixed-rate prime, CRT, Alt-A, subprime and CMBS non-agency securities, respectively, as of
March 31, 2018
.
|
December 31, 2017
|
||||||||||||||||||||||||||||||
|
|
Fair
Value
|
|
Gross Unrealized
|
|
Amortized Cost
|
|
Discount
|
|
Par/ Current Face
|
|
Weighted Average
|
||||||||||||||||||
Category
|
|
|
Gains
|
|
Losses
|
|
|
|
|
Coupon
(1)
|
|
Yield
|
||||||||||||||||||
Prime
|
|
$
|
143,329
|
|
|
$
|
9,342
|
|
|
$
|
(12
|
)
|
|
$
|
133,999
|
|
|
$
|
(13,893
|
)
|
|
$
|
147,892
|
|
|
3.77
|
%
|
|
5.66
|
%
|
CRT
|
|
322,819
|
|
|
18,346
|
|
|
—
|
|
|
304,473
|
|
|
16,011
|
|
|
288,462
|
|
|
5.34
|
%
|
|
5.23
|
%
|
||||||
Alt-A
|
|
286,953
|
|
|
51,123
|
|
|
(774
|
)
|
|
236,604
|
|
|
(112,305
|
)
|
|
348,909
|
|
|
2.69
|
%
|
|
8.93
|
%
|
||||||
Option-ARM
|
|
86,886
|
|
|
13,114
|
|
|
—
|
|
|
73,772
|
|
|
(21,044
|
)
|
|
94,816
|
|
|
1.79
|
%
|
|
6.58
|
%
|
||||||
Subprime
|
|
13,374
|
|
|
929
|
|
|
—
|
|
|
12,445
|
|
|
(683
|
)
|
|
13,128
|
|
|
5.20
|
%
|
|
5.97
|
%
|
||||||
CMBS
|
|
18,723
|
|
|
387
|
|
|
—
|
|
|
18,336
|
|
|
(164
|
)
|
|
18,500
|
|
|
5.68
|
%
|
|
6.03
|
%
|
||||||
Total
|
|
$
|
872,084
|
|
|
$
|
93,241
|
|
|
$
|
(786
|
)
|
|
$
|
779,629
|
|
|
$
|
(132,078
|
)
|
|
$
|
911,707
|
|
|
3.73
|
%
|
|
6.59
|
%
|
(1)
|
Coupon rates are floating, except for
$11.8 million
,
$0.9 million
,
$12.2 million
,
$13.4 million
and
$18.7 million
fair value of fixed-rate prime, CRT, Alt-A, subprime and CMBS non-agency securities, respectively, as of
December 31, 2017
.
|
|
|
March 31, 2018
|
|
December 31, 2017
|
||||||||||||||||||||||||
|
|
|
|
|
|
Weighted Average
|
|
|
|
|
|
Weighted Average
|
||||||||||||||||
Estimated Weighted
Average Life
|
|
Fair Value
|
|
Amortized
Cost
|
|
Coupon
|
|
Yield
|
|
Fair Value
|
|
Amortized
Cost
|
|
Coupon
|
|
Yield
|
||||||||||||
≤ 5 years
|
|
$
|
285,566
|
|
|
$
|
244,884
|
|
|
3.33
|
%
|
|
8.44
|
%
|
|
$
|
302,797
|
|
|
$
|
258,501
|
|
|
3.11
|
%
|
|
8.31
|
%
|
> 5 to ≤ 7 years
|
|
258,753
|
|
|
226,721
|
|
|
4.17
|
%
|
|
7.05
|
%
|
|
398,712
|
|
|
361,649
|
|
|
4.33
|
%
|
|
5.97
|
%
|
||||
> 7 years
|
|
289,362
|
|
|
272,957
|
|
|
4.35
|
%
|
|
5.43
|
%
|
|
170,575
|
|
|
159,479
|
|
|
3.61
|
%
|
|
5.18
|
%
|
||||
Total
|
|
$
|
833,681
|
|
|
$
|
744,562
|
|
|
3.91
|
%
|
|
6.92
|
%
|
|
$
|
872,084
|
|
|
$
|
779,629
|
|
|
3.73
|
%
|
|
6.59
|
%
|
|
March 31, 2018
|
|
December 31, 2017
|
||
Credit Rating
(1)
|
|
|
|
||
AA
|
1
|
%
|
|
1
|
%
|
A
|
1
|
%
|
|
1
|
%
|
BBB
|
10
|
%
|
|
7
|
%
|
BB
|
12
|
%
|
|
14
|
%
|
B
|
19
|
%
|
|
17
|
%
|
Below B
|
24
|
%
|
|
30
|
%
|
Not Rated
|
33
|
%
|
|
30
|
%
|
Total
|
100
|
%
|
|
100
|
%
|
(1)
|
Represents the lowest of Standard and Poor's, Moody's and Fitch credit ratings, stated in terms of the S&P equivalent, as of each respective balance sheet date.
|
March 31, 2018
|
|||||||||||||||||||||
|
|
Fair
Value
|
|
Weighted Average Purchase Price
|
|
Weighted Average
Collateral Attributes
|
|
Weighted Average
Current Performance
|
|||||||||||||
Category
|
|
|
|
Loan Age (months)
|
|
Original LTV
|
|
Original FICO
(1)
|
|
60+ Day Delinquent
(2)
|
|
3-Month CPR
(3)
|
|||||||||
Prime
|
|
$
|
139,841
|
|
|
$
|
85.51
|
|
|
139
|
|
71
|
%
|
|
738
|
|
7
|
%
|
|
15
|
%
|
CRT
|
|
300,338
|
|
|
101.62
|
|
|
27
|
|
79
|
%
|
|
751
|
|
—
|
%
|
|
9
|
%
|
||
Alt-A
|
|
277,083
|
|
|
64.36
|
|
|
148
|
|
76
|
%
|
|
708
|
|
12
|
%
|
|
13
|
%
|
||
Option-ARM
|
|
84,683
|
|
|
71.98
|
|
|
141
|
|
76
|
%
|
|
704
|
|
15
|
%
|
|
11
|
%
|
||
Subprime
|
|
13,337
|
|
|
93.28
|
|
|
156
|
|
77
|
%
|
|
604
|
|
17
|
%
|
|
9
|
%
|
||
CMBS
|
|
18,399
|
|
|
98.92
|
|
|
17
|
|
55
|
%
|
|
NA
|
|
—
|
%
|
|
—
|
%
|
||
Total
|
|
$
|
833,681
|
|
|
$
|
83.38
|
|
|
99
|
|
76
|
%
|
|
711
|
|
7
|
%
|
|
11
|
%
|
December 31, 2017
|
|||||||||||||||||||||
|
|
Fair
Value
|
|
Weighted Average Purchase Price
|
|
Weighted Average
Collateral Attributes
|
|
Weighted Average
Current Performance
|
|||||||||||||
Category
|
|
|
|
Loan Age (months)
|
|
Original LTV
|
|
Original FICO
(1)
|
|
60+ Day Delinquent
(2)
|
|
3-Month CPR
(3)
|
|||||||||
Prime
|
|
$
|
143,329
|
|
|
$
|
85.51
|
|
|
136
|
|
71
|
%
|
|
738
|
|
8
|
%
|
|
18
|
%
|
CRT
|
|
322,819
|
|
|
101.63
|
|
|
32
|
|
76
|
%
|
|
754
|
|
—
|
%
|
|
11
|
%
|
||
Alt-A
|
|
286,953
|
|
|
64.36
|
|
|
145
|
|
76
|
%
|
|
708
|
|
12
|
%
|
|
15
|
%
|
||
Option-ARM
|
|
86,886
|
|
|
71.96
|
|
|
139
|
|
76
|
%
|
|
704
|
|
15
|
%
|
|
11
|
%
|
||
Subprime
|
|
13,374
|
|
|
93.28
|
|
|
153
|
|
77
|
%
|
|
604
|
|
18
|
%
|
|
12
|
%
|
||
CMBS
|
|
18,723
|
|
|
98.92
|
|
|
14
|
|
55
|
%
|
|
NA
|
|
—
|
%
|
|
—
|
%
|
||
Total
|
|
$
|
872,084
|
|
|
$
|
83.06
|
|
|
98
|
|
75
|
%
|
|
713
|
|
7
|
%
|
|
13
|
%
|
(1)
|
FICO represents a mortgage industry accepted credit score of a borrower based on a scale of 300 to 850 with a score of 850 being the highest quality rating.
|
(2)
|
60+ day delinquent represents the percentage of mortgage loans underlying each category of non-agency securities that were delinquent for at least 60 days.
|
(3)
|
Three-month CPR is reflective of the prepayment and default rate on the underlying securitization; however, it does not necessarily indicate the proceeds received on our non-agency securities. Proceeds received for each security are dependent on the position of the individual security within the structure of each deal.
|
|
|
March 31, 2018
|
|
December 31, 2017
|
||
California
|
|
33
|
%
|
|
34
|
%
|
Florida
|
|
7
|
%
|
|
7
|
%
|
New York
|
|
5
|
%
|
|
4
|
%
|
Virginia
|
|
4
|
%
|
|
5
|
%
|
Texas
|
|
4
|
%
|
|
3
|
%
|
Maryland
|
|
4
|
%
|
|
4
|
%
|
Total
|
|
57
|
%
|
|
57
|
%
|
|
|
March 31, 2018
|
|
December 31, 2017
|
||||||||||||||
|
|
|
|
Weighted Average
|
|
|
|
Weighted Average
|
||||||||||
Collateral Type
|
|
Borrowings
Outstanding |
|
Interest Rate
|
|
Days
to Maturity |
|
Borrowings
Outstanding |
|
Interest Rate
|
|
Days
to Maturity |
||||||
Agency securities
|
|
$
|
3,170,784
|
|
|
1.78
|
%
|
|
106
|
|
$
|
3,307,662
|
|
|
1.54
|
%
|
|
114
|
Non-agency securities
|
|
569,380
|
|
|
2.93
|
%
|
|
18
|
|
556,057
|
|
|
2.72
|
%
|
|
24
|
||
U.S. Treasury securities
|
|
3,272
|
|
|
1.65
|
%
|
|
1
|
|
—
|
|
|
N/A
|
|
|
N/A
|
||
Total repurchase agreements
|
|
$
|
3,743,436
|
|
|
1.96
|
%
|
|
92
|
|
$
|
3,863,719
|
|
|
1.71
|
%
|
|
101
|
|
|
March 31, 2018
|
|
December 31, 2017
|
||||||||||||||
|
|
|
|
Weighted Average
|
|
|
|
Weighted Average
|
||||||||||
|
|
Borrowings
Outstanding |
|
Interest Rate
|
|
Days to Maturity
|
|
Borrowings
Outstanding
|
|
Interest Rate
|
|
Days to Maturity
|
||||||
≤ 1 month
|
|
$
|
1,584,501
|
|
|
2.09
|
%
|
|
14
|
|
$
|
1,341,712
|
|
|
1.91
|
%
|
|
17
|
> 1 to ≤ 2 months
|
|
955,061
|
|
|
1.80
|
%
|
|
43
|
|
1,334,493
|
|
|
1.55
|
%
|
|
40
|
||
> 2 to ≤ 3 months
|
|
342,533
|
|
|
1.95
|
%
|
|
78
|
|
295,204
|
|
|
1.76
|
%
|
|
76
|
||
> 3 to ≤ 6 months
|
|
510,378
|
|
|
1.71
|
%
|
|
155
|
|
334,372
|
|
|
1.51
|
%
|
|
123
|
||
> 6 to ≤ 12 months
|
|
85,963
|
|
|
2.04
|
%
|
|
301
|
|
292,938
|
|
|
1.57
|
%
|
|
256
|
||
> 12 months
|
|
265,000
|
|
|
2.18
|
%
|
|
568
|
|
265,000
|
|
|
1.80
|
%
|
|
658
|
||
Total repurchase agreements
|
|
$
|
3,743,436
|
|
|
1.96
|
%
|
|
92
|
|
$
|
3,863,719
|
|
|
1.71
|
%
|
|
101
|
Current Maturity Date
(1)
|
|
March 31, 2018
|
|
December 31, 2017
|
||||||||||||||||||||
|
Notional
Amount |
|
Weighted Average
|
|
Notional
Amount |
|
Weighted Average
|
|||||||||||||||||
|
|
Fixed
Pay Rate (2) |
|
Receive
Rate (3) |
|
Maturity
(Years)
|
|
|
Fixed Pay Rate
(2)
|
|
Receive
Rate (3) |
|
Maturity
(Years)
|
|||||||||||
≤ 3 years
|
|
$
|
1,600,000
|
|
|
1.31
|
%
|
|
1.90
|
%
|
|
1.2
|
|
$
|
1,500,000
|
|
|
1.26
|
%
|
|
1.46
|
%
|
|
1.3
|
> 3 to ≤ 5 years
|
|
935,000
|
|
|
1.77
|
%
|
|
1.94
|
%
|
|
3.9
|
|
985,000
|
|
|
1.79
|
%
|
|
1.47
|
%
|
|
4.0
|
||
> 5 to ≤ 7 years
|
|
400,000
|
|
|
1.98
|
%
|
|
1.79
|
%
|
|
5.4
|
|
350,000
|
|
|
1.78
|
%
|
|
1.40
|
%
|
|
5.7
|
||
> 7 years
|
|
695,000
|
|
|
2.26
|
%
|
|
1.96
|
%
|
|
9.6
|
|
695,000
|
|
|
2.26
|
%
|
|
1.47
|
%
|
|
9.9
|
||
Total
|
|
$
|
3,630,000
|
|
|
1.68
|
%
|
|
1.91
|
%
|
|
4.0
|
|
$
|
3,530,000
|
|
|
1.65
|
%
|
|
1.46
|
%
|
|
4.2
|
(1)
|
Includes swaps with an aggregate notional of
$0.2 billion
and
$0.4 billion
with deferred start dates averaging
0.0 years
and
0.1 years
from
March 31, 2018 and December 31, 2017
, respectively.
|
(2)
|
Excluding forward starting swaps, the weighted average pay rate was
1.64%
and
1.58%
as of
March 31, 2018 and December 31, 2017
, respectively.
|
(3)
|
Weighted average receive rate excludes impact of forward starting interest rate swaps.
|
March 31, 2018
|
|||||||||||||||||||
|
|
Option
|
|
Underlying Swap
|
|||||||||||||||
Current Option Expiration Date
|
|
Cost
|
|
Fair Value
|
|
Weighted Average Years to Expiration
|
|
Notional Amount
|
|
Pay Rate
|
|
Weighted Average Term (Years)
|
|||||||
|
|
|
|
|
|
||||||||||||||
≤ 12 months
|
|
$
|
2,341
|
|
|
$
|
3,979
|
|
|
0.7
|
|
$
|
200,000
|
|
|
2.73
|
%
|
|
8.4
|
>12 to ≤ 24 months
|
|
2,623
|
|
|
3,077
|
|
|
1.2
|
|
125,000
|
|
|
2.86
|
%
|
|
8.4
|
|||
> 24 months
|
|
7,951
|
|
|
5,764
|
|
|
3.2
|
|
175,000
|
|
|
2.87
|
%
|
|
8.7
|
|||
Total / weighted average
|
|
$
|
12,915
|
|
|
$
|
12,820
|
|
|
1.7
|
|
$
|
500,000
|
|
|
2.81
|
%
|
|
8.5
|
December 31, 2017
|
|||||||||||||||||||
|
|
Option
|
|
Underlying Swap
|
|||||||||||||||
Current Option Expiration Date
|
|
Cost
|
|
Fair Value
|
|
Weighted Average Years to Expiration
|
|
Notional Amount
|
|
Pay Rate
|
|
Weighted Average Term (Years)
|
|||||||
|
|
|
|
|
|
||||||||||||||
< 12 months
|
|
$
|
2,111
|
|
|
$
|
1,621
|
|
|
0.9
|
|
$
|
175,000
|
|
|
2.71
|
%
|
|
8.6
|
>12 to ≤ 24 months
|
|
2,083
|
|
|
1,400
|
|
|
1.5
|
|
75,000
|
|
|
2.73
|
%
|
|
10.0
|
|||
> 24 months
|
|
7,951
|
|
|
3,707
|
|
|
3.4
|
|
175,000
|
|
|
2.87
|
%
|
|
8.9
|
|||
Total / weighted average
|
|
$
|
12,145
|
|
|
$
|
6,728
|
|
|
2.0
|
|
$
|
425,000
|
|
|
2.78
|
%
|
|
8.9
|
|
|
For the Three Months Ended March 31,
|
||||||
|
|
2018
|
|
2017
|
||||
Interest income:
|
|
|
|
|
||||
Agency securities
|
|
$
|
27,511
|
|
|
$
|
17,901
|
|
Non-agency securities
|
|
11,994
|
|
|
15,696
|
|
||
Other
|
|
125
|
|
|
160
|
|
||
Interest expense
|
|
(17,053
|
)
|
|
(10,165
|
)
|
||
Net interest income
|
|
22,577
|
|
|
23,592
|
|
||
|
|
|
|
|
||||
Healthcare real estate:
|
|
|
|
|
||||
Healthcare real estate income
|
|
7,760
|
|
|
3,315
|
|
||
Healthcare real estate expense
|
|
(5,795
|
)
|
|
(2,653
|
)
|
||
Net healthcare investment income
|
|
1,965
|
|
|
662
|
|
||
|
|
|
|
|
||||
Other gains (losses):
|
|
|
|
|
||||
Realized loss on agency securities, net
|
|
(1,940
|
)
|
|
(212
|
)
|
||
Realized gain on non-agency securities, net
|
|
4,154
|
|
|
12,714
|
|
||
Realized gain (loss) on periodic settlements of interest rate swaps, net
|
|
358
|
|
|
(2,660
|
)
|
||
Realized gain on other derivatives and securities, net
|
|
2,736
|
|
|
2,167
|
|
||
Unrealized loss on agency securities, net
|
|
(76,170
|
)
|
|
(115
|
)
|
||
Unrealized gain (loss) on non-agency securities, net
|
|
(3,337
|
)
|
|
13,014
|
|
||
Unrealized gain (loss) on other derivatives and securities, net
|
|
33,457
|
|
|
(2,839
|
)
|
||
Servicing income
|
|
50
|
|
|
2,558
|
|
||
Servicing expense
|
|
(250
|
)
|
|
(4,985
|
)
|
||
Total other gains (losses), net
|
|
(40,942
|
)
|
|
19,642
|
|
||
Expenses:
|
|
|
|
|
||||
Management fees
|
|
3,389
|
|
|
3,376
|
|
||
General and administrative expenses
|
|
1,578
|
|
|
1,719
|
|
||
Total expenses
|
|
4,967
|
|
|
5,095
|
|
||
Net income (loss)
|
|
(21,367
|
)
|
|
38,801
|
|
||
Dividend on preferred stock
|
|
(1,117
|
)
|
|
(1,117
|
)
|
||
Noncontrolling interest in net loss (income)
|
|
5
|
|
|
(2
|
)
|
||
Net income (loss) available to common stockholders
|
|
$
|
(22,479
|
)
|
|
$
|
37,682
|
|
|
|
|
|
|
||||
Net income (loss) per common share — basic and diluted
|
|
$
|
(0.49
|
)
|
|
$
|
0.82
|
|
|
|
|
|
|
||||
Weighted average common shares — basic
|
|
45,810
|
|
|
45,798
|
|
||
Weighted average common shares — diluted
|
|
45,822
|
|
|
45,806
|
|
||
|
|
|
|
|
||||
Dividend declared per common share
|
|
$
|
0.50
|
|
|
$
|
0.45
|
|
|
|
For the Three Months Ended March 31,
|
||||||||||||||||||||
|
|
2018
|
|
2017
|
||||||||||||||||||
|
|
Average Amortized Cost
|
|
Weighted Average Yield
|
|
Interest Income
|
|
Average Amortized Cost
|
|
Weighted Average Yield
|
|
Interest Income
|
||||||||||
Agency RMBS
(1)
|
|
$
|
3,672,651
|
|
|
3.00
|
%
|
|
$
|
27,511
|
|
|
$
|
2,762,718
|
|
|
2.59
|
%
|
|
$
|
17,901
|
|
Non-agency securities
|
|
738,842
|
|
|
6.49
|
%
|
|
11,994
|
|
|
1,009,041
|
|
|
6.22
|
%
|
|
15,696
|
|
||||
Total
|
|
$
|
4,411,493
|
|
|
3.58
|
%
|
|
$
|
39,505
|
|
|
$
|
3,771,759
|
|
|
3.56
|
%
|
|
$
|
33,597
|
|
(1)
|
Does not include TBA dollar roll income reported in realized gain (loss) on other derivatives and securities, net in our consolidated statements of operations.
|
|
|
For the Three Months Ended March 31, 2018 vs. 2017
|
||||||||||
|
|
Increase / (Decrease)
|
|
Due to Change in Average
(1)
|
||||||||
|
|
|
Volume
|
|
Yield
|
|||||||
Agency RMBS
|
|
$
|
9,610
|
|
|
$
|
6,490
|
|
|
$
|
3,120
|
|
Non-agency securities
|
|
(3,702
|
)
|
|
(4,418
|
)
|
|
716
|
|
|||
Total
|
|
$
|
5,908
|
|
|
$
|
2,072
|
|
|
$
|
3,836
|
|
(1)
|
Variances that are the combined effect of volume and yield, but cannot be separately identified, are allocated to the volume and yield variances based on their respective relative amounts.
|
|
|
Repurchase Agreements and Advances
(1)
|
|
Average
Interest
Rate as of Period End
(1)
|
|
Average Leverage During the Period
(2)
|
|
Leverage as of Period End
(3)
|
|
Adjusted Leverage as of Period End
(4)
|
|||||||||||
Quarter Ended
|
|
Average Daily Amount Outstanding
|
|
Maximum Daily Amount Outstanding
|
|
Ending Amount Outstanding
|
|
||||||||||||||
March 31, 2018
|
|
$
|
3,717,094
|
|
|
$
|
3,883,304
|
|
|
$
|
3,743,436
|
|
|
1.96
|
%
|
|
4.2x
|
|
4.4x
|
|
6.2x
|
December 31, 2017
|
|
$
|
3,784,846
|
|
|
$
|
3,873,054
|
|
|
$
|
3,863,719
|
|
|
1.71
|
%
|
|
4.2x
|
|
4.2x
|
|
6.2x
|
September 30, 2017
|
|
$
|
3,650,206
|
|
|
$
|
3,893,263
|
|
|
$
|
3,807,880
|
|
|
1.58
|
%
|
|
4.1x
|
|
4.2x
|
|
6.3x
|
June 30, 2017
|
|
$
|
3,538,006
|
|
|
$
|
3,836,940
|
|
|
$
|
3,805,778
|
|
|
1.47
|
%
|
|
4.0x
|
|
4.4x
|
|
6.3x
|
March 31, 2017
|
|
$
|
3,117,397
|
|
|
$
|
3,272,548
|
|
|
$
|
3,185,134
|
|
|
1.31
|
%
|
|
3.5x
|
|
3.6x
|
|
5.9x
|
December 31, 2016
|
|
$
|
3,677,854
|
|
|
$
|
3,554,251
|
|
|
$
|
3,244,516
|
|
|
1.26
|
%
|
|
3.8x
|
|
3.7x
|
|
4.8x
|
September 30, 2016
|
|
$
|
3,682,233
|
|
|
$
|
3,781,117
|
|
|
$
|
3,553,666
|
|
|
1.11
|
%
|
|
4.0x
|
|
3.7x
|
|
5.0x
|
June 30, 2016
|
|
$
|
3,692,354
|
|
|
$
|
4,306,868
|
|
|
$
|
3,555,883
|
|
|
1.04
|
%
|
|
4.2x
|
|
4.5x
|
|
4.9x
|
March 31, 2016
|
|
$
|
3,933,580
|
|
|
$
|
4,291,269
|
|
|
$
|
3,844,759
|
|
|
1.00
|
%
|
|
4.4x
|
|
4.4x
|
|
4.6x
|
(1)
|
Excludes repurchase agreements collateralized by U.S. Treasury securities and borrowings related to our healthcare investments, but includes advances from the Federal Home Loan Bank collateralized by agency and non-agency securities.
|
(2)
|
Average leverage during the period was calculated by dividing our daily weighted average agency and non-agency financing balance by our average month-end stockholders’ equity for the period, less investments in RCS and healthcare real estate.
|
(3)
|
Leverage as of period end was calculated by dividing the amount outstanding under our agency and non-agency financing agreements and net payables and receivables for unsettled agency and non-agency securities by our total stockholders' equity at period end, less our investments in RCS and healthcare real estate.
|
(4)
|
Adjusted leverage as of period end was calculated by dividing the sum of the amounts outstanding under our agency and non-agency financing agreements, the cost basis (or contract price) of our net TBA position, and net payables and receivables for unsettled agency and non-agency securities by our total stockholders’ equity at period end, less our investments in RCS and healthcare real estate.
|
|
|
For the Three Months Ended March 31,
|
||||||||||||||||||
|
|
2018
|
|
2017
|
||||||||||||||||
|
|
Average
Balance / Effective Notional |
|
Rate
|
|
Adjusted Cost of Funds
(1)
|
|
Average
Balance / Effective Notional |
|
Rate
|
|
Adjusted Cost of Funds
(1)
|
||||||||
Repurchase agreements
|
|
$
|
3,717,094
|
|
|
1.86%
|
|
$
|
17,053
|
|
|
$
|
3,117,397
|
|
|
1.32%
|
|
$
|
10,165
|
|
Interest rate swaps
|
|
3,362,500
|
|
|
(0.04)%
|
|
(358
|
)
|
|
2,887,500
|
|
|
0.37%
|
|
2,660
|
|
||||
Total adjusted cost of funds
|
|
|
|
1.82%
|
|
$
|
16,695
|
|
|
|
|
1.67%
|
|
$
|
12,825
|
|
(1)
|
Our adjusted cost of funds excludes any impacts from other supplemental hedges such as U.S. Treasury securities and swaptions, and the implied financing cost or benefit of our net TBA dollar roll position reported in gain (loss) on other derivatives and securities, net in our consolidated statements of operations.
|
|
|
For the Three Months Ended March 31, 2018 vs. 2017
|
||||||||||
|
|
Increase / (Decrease)
|
|
Due to Change in Average
(1)
|
||||||||
|
|
|
Volume
|
|
Rate
|
|||||||
Repurchase agreements
|
|
$
|
6,888
|
|
|
$
|
2,201
|
|
|
$
|
4,687
|
|
Interest rate swaps
|
|
(3,018
|
)
|
|
(365
|
)
|
|
(2,653
|
)
|
|||
Total adjusted cost of funds
|
|
$
|
3,870
|
|
|
$
|
1,836
|
|
|
$
|
2,034
|
|
(1)
|
Variances that are the combined effect of volume and yield, but cannot be separately identified, are allocated to the volume and yield variances based on their respective relative amounts.
|
|
|
For the Three Months Ended March 31,
|
||||||
|
|
2018
|
|
2017
|
||||
Lease income
|
|
$
|
5,706
|
|
|
$
|
2,253
|
|
Rental income
|
|
2,054
|
|
|
1,062
|
|
||
Healthcare real estate income
|
|
7,760
|
|
|
3,315
|
|
||
|
|
|
|
|
||||
Interest expense
|
|
2,089
|
|
|
1,173
|
|
||
Depreciation
|
|
2,001
|
|
|
771
|
|
||
Tenant expenses
|
|
1,425
|
|
|
709
|
|
||
Other
|
|
280
|
|
|
—
|
|
||
Healthcare real estate expense
|
|
5,795
|
|
|
2,653
|
|
||
Net healthcare investment income
|
|
$
|
1,965
|
|
|
$
|
662
|
|
|
|
For the Three Months Ended March 31,
|
||||||
|
|
2018
|
|
2017
|
||||
Proceeds from agency securities sold
|
|
$
|
220,435
|
|
|
$
|
208,457
|
|
Less agency securities sold, at cost
|
|
(222,375
|
)
|
|
(208,669
|
)
|
||
Realized loss on agency securities, net
|
|
$
|
(1,940
|
)
|
|
$
|
(212
|
)
|
|
|
|
|
|
||||
Gross realized gains on sale of agency securities
|
|
$
|
14
|
|
|
$
|
1,270
|
|
Gross realized losses on sale of agency securities
|
|
(1,954
|
)
|
|
(1,482
|
)
|
||
Realized loss on agency securities, net
|
|
$
|
(1,940
|
)
|
|
$
|
(212
|
)
|
|
|
For the Three Months Ended March 31,
|
||||||
|
|
2018
|
|
2017
|
||||
Proceeds from non-agency securities sold
|
|
$
|
89,901
|
|
|
$
|
260,473
|
|
Increase in receivable for securities sold
|
|
—
|
|
|
5,748
|
|
||
Less: non-agency securities sold, at cost
|
|
(85,747
|
)
|
|
(253,507
|
)
|
||
Realized gain on non-agency securities, net
|
|
$
|
4,154
|
|
|
$
|
12,714
|
|
|
|
|
|
|
||||
Gross realized gain on sale of non-agency securities
|
|
$
|
4,155
|
|
|
$
|
12,864
|
|
Gross realized loss on sale of non-agency securities
|
|
(1
|
)
|
|
(150
|
)
|
||
Realized gain on non-agency securities, net
|
|
$
|
4,154
|
|
|
$
|
12,714
|
|
|
|
For the Three Months Ended March 31,
|
||||||
|
|
2018
|
|
2017
|
||||
Realized gain (loss) on periodic settlements of interest rate swaps, net
|
|
$
|
358
|
|
|
$
|
(2,660
|
)
|
Realized gain on other derivatives and securities:
|
|
|
|
|
||||
Interest rate swaps
|
|
$
|
47,929
|
|
|
$
|
26,021
|
|
TBA securities
|
|
(43,145
|
)
|
|
(24,290
|
)
|
||
Short sales of U.S. Treasury securities
|
|
(389
|
)
|
|
251
|
|
||
Credit default swaps
|
|
(1,648
|
)
|
|
(43
|
)
|
||
Other, net
|
|
(11
|
)
|
|
228
|
|
||
Total realized gain on other derivatives and securities, net
|
|
$
|
2,736
|
|
|
$
|
2,167
|
|
Unrealized gain (loss) on other derivatives and securities:
|
|
|
|
|
||||
Interest rate swaps
|
|
$
|
2,120
|
|
|
$
|
(21,830
|
)
|
Interest rate swaptions
|
|
5,322
|
|
|
(428
|
)
|
||
TBA securities
|
|
7,959
|
|
|
29,510
|
|
||
Short sales of U.S. Treasury securities
|
|
16,503
|
|
|
(9,641
|
)
|
||
Credit default swaps
|
|
1,528
|
|
|
(457
|
)
|
||
Other, net
|
|
25
|
|
|
7
|
|
||
Total unrealized gain (loss) on other derivatives and securities, net
|
|
$
|
33,457
|
|
|
$
|
(2,839
|
)
|
|
|
For the Three Months Ended March 31,
|
||||||
|
|
2018
|
|
2017
|
||||
Net income
|
|
$
|
(21,367
|
)
|
|
$
|
38,801
|
|
Book to tax differences:
|
|
|
|
|
||||
Unrealized (gains) and losses, net
|
|
|
|
|
||||
Agency RMBS
|
|
76,170
|
|
|
115
|
|
||
Non-agency securities
|
|
3,337
|
|
|
(13,014
|
)
|
||
Derivatives, MSR and other securities
|
|
(33,457
|
)
|
|
2,839
|
|
||
Amortization / accretion
|
|
(1,094
|
)
|
|
(1,174
|
)
|
||
Capital gains
(1)
|
|
40,859
|
|
|
13,716
|
|
||
Realized losses (gains), net
(1)
|
|
(54,952
|
)
|
|
(37,324
|
)
|
||
Taxable REIT subsidiary loss and other
|
|
200
|
|
|
2,427
|
|
||
Total book to tax difference
|
|
31,063
|
|
|
(32,415
|
)
|
||
Estimated taxable income
|
|
9,696
|
|
|
6,386
|
|
||
Dividend on preferred stock
|
|
(1,117
|
)
|
|
(1,117
|
)
|
||
Estimated taxable income available to common stockholders
|
|
$
|
8,579
|
|
|
$
|
5,269
|
|
|
|
|
|
|
||||
Weighted average common shares — basic
|
|
45,810
|
|
|
45,798
|
|
||
Weighted average common shares — diluted
|
|
45,822
|
|
|
45,806
|
|
||
|
|
|
|
|
||||
Estimated taxable income per common share - basic and diluted
|
|
$
|
0.19
|
|
|
$
|
0.12
|
|
Ending cumulative (overdistribution) of estimated taxable income per common share
|
|
$
|
(1.93
|
)
|
|
$
|
(0.82
|
)
|
|
|
|
|
|
||||
Beginning cumulative non-deductible capital losses
|
|
$
|
73,252
|
|
|
$
|
118,347
|
|
Current period net capital gain
|
|
40,859
|
|
|
13,716
|
|
||
Ending cumulative non-deductible capital losses
|
|
$
|
114,111
|
|
|
$
|
132,063
|
|
Ending cumulative non-deductible capital losses per common share
|
|
$
|
2.49
|
|
|
$
|
2.88
|
|
(1)
|
Estimated taxable income excludes estimated net capital losses of
$(0.89)
per common share for
the three months ended March 31, 2018
, respectively, which increase our net capital loss carryforwards from prior periods.
|
|
|
For the Three Months Ended March 31,
|
||||||
|
|
2018
|
|
2017
|
||||
Ending agency securities, at fair value
|
|
$
|
3,660,403
|
|
|
$
|
2,997,725
|
|
Ending agency securities, at cost
|
|
$
|
3,771,472
|
|
|
$
|
3,031,237
|
|
Ending agency securities, at par
|
|
$
|
3,589,608
|
|
|
$
|
2,881,851
|
|
Average agency securities, at cost
|
|
$
|
3,672,651
|
|
|
$
|
2,762,718
|
|
Average agency securities, at par
|
|
$
|
3,491,456
|
|
|
$
|
2,629,607
|
|
|
|
|
|
|
||||
Ending non-agency securities, at fair value
|
|
$
|
833,681
|
|
|
$
|
948,495
|
|
Ending non-agency securities, at cost
|
|
$
|
744,562
|
|
|
$
|
880,376
|
|
Ending non-agency securities, at par
|
|
$
|
874,844
|
|
|
$
|
1,039,185
|
|
Average non-agency securities, at cost
|
|
$
|
738,842
|
|
|
$
|
1,009,041
|
|
Average non-agency securities, at par
|
|
$
|
870,646
|
|
|
$
|
1,187,097
|
|
|
|
|
|
|
||||
Net TBA portfolio - as of period end, at fair value
|
|
$
|
1,582,747
|
|
|
$
|
2,081,093
|
|
Net TBA portfolio - as of period end, at cost
|
|
$
|
1,573,036
|
|
|
$
|
2,070,072
|
|
Average net TBA portfolio, at cost
|
|
$
|
1,791,969
|
|
|
$
|
1,366,814
|
|
|
|
|
|
|
||||
Average total assets, at fair value
|
|
$
|
5,773,121
|
|
|
$
|
5,044,712
|
|
Average agency and non-agency repurchase agreements and advances
|
|
$
|
3,717,094
|
|
|
$
|
3,117,397
|
|
Average stockholders' equity
|
|
$
|
985,289
|
|
|
$
|
946,266
|
|
|
|
|
|
|
||||
Average coupon
|
|
3.69
|
%
|
|
3.38
|
%
|
||
Average asset yield
|
|
3.58
|
%
|
|
3.56
|
%
|
||
Average asset yield excluding “catch-up” premium amortization
|
|
3.44
|
%
|
|
3.63
|
%
|
||
Average cost of funds
(1)
|
|
1.82
|
%
|
|
1.67
|
%
|
||
Average net interest rate spread
|
|
1.76
|
%
|
|
1.89
|
%
|
||
Average net interest rate spread, excluding “catch-up” premium amortization
|
|
1.62
|
%
|
|
1.96
|
%
|
||
Average net interest rate spread, including TBA dollar roll, excluding “catch-up” premium amortization
|
|
1.64
|
%
|
|
2.05
|
%
|
||
Average coupon as of period end
|
|
3.70
|
%
|
|
3.54
|
%
|
||
Average asset yield as of period end
|
|
3.54
|
%
|
|
3.60
|
%
|
||
Average repurchase agreement/ FHLB funding rate as of period end
|
|
1.96
|
%
|
|
1.31
|
%
|
||
Effective swap net pay rate as of period end
|
|
(0.27
|
)%
|
|
0.31
|
%
|
(1)
|
Average cost of funds includes periodic settlements of interest rate swaps and excludes U.S. Treasury repurchase agreements and healthcare real estate financing.
|
(2)
|
Leverage during the period was calculated by dividing the Company's daily weighted average agency and non-agency financing agreements for the period by the Company's average month-ended stockholders' equity for the period less investments in RCS and healthcare real estate. Leverage excludes U.S. Treasury repurchase agreements.
|
(3)
|
Leverage at period end was calculated by dividing the sum of the amount outstanding under the Company's agency and non-agency financing agreements, and the net receivable/payable for unsettled securities at period end by the Company's stockholders' equity at period end less investments in RCS and healthcare real estate. Leverage excludes U.S. Treasury repurchase agreements.
|
|
|
For the Three Months Ended March 31,
|
||||||
|
|
2018
|
|
2017
|
||||
Interest income:
|
|
|
|
|
||||
Agency securities
|
|
$
|
27,511
|
|
|
$
|
17,901
|
|
Non-agency securities and other
|
|
12,119
|
|
|
15,856
|
|
||
Interest expense
|
|
(17,053
|
)
|
|
(10,165
|
)
|
||
Net interest income
|
|
22,577
|
|
|
23,592
|
|
||
Realized gain (loss) on periodic settlements of interest rate swaps, net
|
|
358
|
|
|
(2,660
|
)
|
||
Dollar roll income
|
|
7,465
|
|
|
7,271
|
|
||
Adjusted net interest and dollar roll income
|
|
30,400
|
|
|
28,203
|
|
||
Operating expenses
|
|
(4,967
|
)
|
|
(5,095
|
)
|
||
Net spread and dollar roll income
|
|
25,433
|
|
|
23,108
|
|
||
Dividend on preferred stock
|
|
(1,117
|
)
|
|
(1,117
|
)
|
||
Net spread and dollar roll income available to common stockholders
|
|
24,316
|
|
|
21,991
|
|
||
Estimated “catch-up” premium amortization cost due to change in CPR forecast
|
|
(1,563
|
)
|
|
645
|
|
||
Net spread and dollar roll income, excluding “catch-up” premium amortization, available to common stockholders
|
|
$
|
22,753
|
|
|
$
|
22,636
|
|
|
|
|
|
|
||||
Weighted average common shares — basic
|
|
45,810
|
|
|
45,798
|
|
||
Weighted average common shares — diluted
|
|
45,822
|
|
|
45,806
|
|
||
|
|
|
|
|
||||
Net spread and dollar roll income per common share- basic and diluted
|
|
$
|
0.53
|
|
|
$
|
0.48
|
|
Net spread and dollar roll income, excluding “catch up” amortization per common share - basic and diluted
|
|
$
|
0.50
|
|
|
$
|
0.49
|
|
|
|
March 31, 2018
|
||
Counterparty Region
|
|
Number of Counterparties
|
|
Percentage of Repurchase Agreement Funding
|
North America
|
|
18
|
|
67%
|
Asia
|
|
6
|
|
10%
|
Europe
|
|
12
|
|
23%
|
Total
|
|
36
|
|
100%
|
Interest Rate Sensitivity
(1)
|
|||||||||
|
|
Percentage Change in Projected
|
|||||||
Change in Interest Rate
|
|
Net Interest Income
(2)
|
|
Portfolio Value
(3) (4)
|
|
Net Asset Value
(3) (5)
|
|||
March 31, 2018
|
|
|
|
|
|
|
|||
+100 basis points
|
|
5.5
|
%
|
|
(1.5
|
)%
|
|
(10.4
|
)%
|
+50 basis points
|
|
2.4
|
%
|
|
(0.7
|
)%
|
|
(4.6
|
)%
|
-50 basis points
|
|
(4.2
|
)%
|
|
0.4
|
%
|
|
2.8
|
%
|
-100 basis points
|
|
(9.3
|
)%
|
|
0.4
|
%
|
|
3.0
|
%
|
December 31, 2017
|
|
|
|
|
|
|
|||
+100 basis points
|
|
6.8
|
%
|
|
(1.2
|
)%
|
|
(8.2
|
)%
|
+50 basis points
|
|
3.9
|
%
|
|
(0.5
|
)%
|
|
(3.1
|
)%
|
-50 basis points
|
|
(5.4
|
)%
|
|
0.1
|
%
|
|
0.3
|
%
|
-100 basis points
|
|
(14.0
|
)%
|
|
(0.4
|
)%
|
|
(2.8
|
)%
|
(1)
|
Interest rate sensitivity is derived from models that are dependent on inputs and assumptions provided by third parties as well as by our Manager, assumes there are no changes in mortgage spreads and assumes a static portfolio. Actual results could differ materially from these estimates.
|
(2)
|
Represents the estimated dollar change in net interest income expressed as a percentage of net interest income based on asset yields and cost of funds as of such date. It includes the effect of periodic interest costs on our interest rate swaps, but excludes TBA dollar roll income and costs associated with other supplemental hedges, such as swaptions and U.S. Treasury securities or TBA positions. Estimated dollar change in net interest income does not include the one time impact of retroactive “catch-up” premium amortization benefit/cost due to an increase/decrease in the projected CPR.
|
(5)
|
Estimated change in net asset value expressed as a percentage of stockholders' equity.
|
Agency RMBS Spread Sensitivity
(1)
|
||||||
|
|
Percentage Change in Projected
|
||||
Change in Spread
|
|
Portfolio Market Value
(2) (3)
|
|
Net Asset
Value
(2) (4)
|
||
March 31, 2018
|
|
|
|
|
||
-25 basis points
|
|
1.3
|
%
|
|
8.5
|
%
|
-10 basis points
|
|
0.5
|
%
|
|
3.4
|
%
|
+10 basis points
|
|
(0.5
|
)%
|
|
(3.4
|
)%
|
+25 basis points
|
|
(1.3
|
)%
|
|
(8.5
|
)%
|
December 31, 2017
|
|
|
|
|
||
-25 basis points
|
|
1.2
|
%
|
|
7.9
|
%
|
-10 basis points
|
|
0.5
|
%
|
|
3.2
|
%
|
+10 basis points
|
|
(0.5
|
)%
|
|
(3.2
|
)%
|
+25 basis points
|
|
(1.2
|
)%
|
|
(7.9
|
)%
|
(1)
|
Spread sensitivity is derived from models that are dependent on inputs and assumptions provided by third parties as well as by our Manager, and assumes there are no changes in interest rates and a static portfolio. Actual results could differ materially from these estimates.
|
(4)
|
Estimated dollar change in net asset value expressed as a percentage of stockholders' equity as of such date.
|
Exhibit No.
|
|
Description
|
*3.1
|
|
|
|
|
|
3.2
|
|
|
|
|
|
*3.3
|
|
|
|
|
|
*4.1
|
|
|
|
|
|
*4.2
|
|
|
|
|
|
*4.3
|
|
|
|
|
|
*4.4
|
|
|
|
|
|
31.1
|
|
|
|
|
|
31.2
|
|
|
|
|
|
32
|
|
|
|
|
|
101.INS**
|
|
XBRL Instance Document
|
|
|
|
101.SCH**
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
101.CAL**
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
101.LAB**
|
|
XBRL Taxonomy Extension Labels Linkbase Document
|
|
|
|
101.PRE**
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
|
101.DEF**
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
By:
|
|
/s/ SEAN P. REID
|
|
|
SEAN P. REID
|
|
|
Chief Executive Officer
(Principal Executive Officer)
|
By:
|
|
/s/ DONALD W. HOLLEY
|
|
|
DONALD W. HOLLEY
|
|
|
Chief Financial Officer and
Senior Vice President (Principal Financial Officer)
|
(2)
|
Such stockholder’s notice shall set forth:
|
(ii)
|
as to any other business that the stockholder proposes to bring
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c)
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and
|
d)
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an Annual Report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date:
|
May 10, 2018
|
|
By:
|
/s/ SEAN P. REID
|
|
|
|
|
Sean P. Reid
Chief Executive Officer
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c)
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and
|
d)
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an Annual Report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date:
|
May 10, 2018
|
|
By:
|
/s/ DONALD W. HOLLEY
|
|
|
|
|
Donald W. Holley
Chief Financial Officer and
Senior Vice President
|
1.
|
The Quarterly Report on Form 10-Q of the Company for the quarterly period ended
March 31, 2018
(the “Report”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 (15 U.S.C. 78m); and
|
2.
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Date:
|
May 10, 2018
|
|
By:
|
/s/ SEAN P. REID
|
|
|
|
|
Sean P. Reid
Chief Executive Officer
|
|
|
|
|
|
Date:
|
May 10, 2018
|
|
By:
|
/s/ DONALD W. HOLLEY
|
|
|
|
|
Donald W. Holley
Chief Financial Officer and Senior Vice President |